Вы находитесь на странице: 1из 94

INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED

Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[400100] Disclosure of general information about company


Unless otherwise specified, all monetary values are in INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Corporate identity number U85110OR2011PTC013803
Permanent account number of entity AACCI9709F
PLOT NO. 1460/61, N-1,,
IRC VILLAGE, NAYAPALLI,,
Address of registered office of company BHUBANESWAR, Khordha,
Orissa, 751015, India,
Commercial and
Type of industry Industrial
Registration date 23/06/2011
C omme r c i a l a n
Category/sub-category of company d Industrial
Whether company is listed company No
Date of board meeting when final accounts were approved 07/09/2019
Period covered by financial statements 12 MONTHS 12 MONTHS
Date of start of reporting period 01/04/2018 01/04/2017
Date of end of reporting period 31/03/2019 31/03/2018
Nature of report standalone consolidated Standalone
Content of report Financial Statements
Description of presentation currency INR
Level of rounding used in financial statements Actual
Type of cash flow statement Direct Method
Whether company is maintaining books of account and other
Yes
relevant books and papers in electronic form
Complete postal address of place of maintenance of computer p l o t n o - 1 5 5 , s a h i d n a g
servers (storing accounting data) a r , bhubaneswar-751007
Name of city of place of maintenance of computer servers (storing
bhubaneswar
accounting data)
Name of state/ union territory of place of maintenance of
ODISHA
computer servers (storing accounting data)
Pin code of place of maintenance of computer servers (storing
751007
accounting data)
Name of district of place of maintenance of computer servers
KHURDHA
(storing accounting data)
ISO country code of place of maintenance of computer servers
91
(storing accounting data)
Name of country of place of maintenance of computer servers
IN
(storing accounting data)
Phone (with STD/ ISD code) of place of maintenance of computer
06742553334
servers (storing accounting data)
Whether books of account and other books and papers are maintained
No
on cloud
Total number of product or service category ONE
Description of principal product or services category HUMAN HEALTH SERVICES
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of principal product or services [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Types of principal product or services [Axis] SERVICE
01/04/2018
to
31/03/2019
Disclosure of general information about company [Abstract]
Disclosure of principal product or services [Abstract]
Disclosure of principal product or services [LineItems]
Product or service category (ITC 4 digit) code 9993
HUMAN HEALTH
Description of product or service category SERVICES
Turnover of product or service category 11,95,18,857.9
Highest turnover contributing product or service (ITC 8 digit) code 99931210
GENERAL
Description of product or service MEDICAL
SERVICES
Turnover of highest contributing product or service 11,95,18,857.9

[400400] Disclosures - Directors report

Details of material contracts/arrangements/transactions at arm's length basis [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Material
contracts/arrangements/transactions at CONTRACTARRANGEMENT1 CONTRACTARRANGEMENT2 CONTRACTARRANGEMENT3 CONTRACTARRANGEMEN
arm's length basis [Axis]
01/04/2018 01/04/2018 01/04/2018 01/04/2018
to to to to
31/03/2019 31/03/2019 31/03/2019 31/03/2019
Name of related party Kedarnath Panda Subodh Das Brundaban Nahak Manoranjan Mohapatra
Key managerial personnel or his Key managerial personnel or his Key managerial personnel or his Key managerial personnel or
Nature of related party relationship relative relative relative relative
Details of material
contracts/arrangements/transactions at
arm's
length basis [Abstract]
Details of material
contracts/arrangements/transactions
at arm's
length basis [LineItems]
Name of related party Kedarnath Panda Subodh Das Brundaban Nahak Manoranjan Mohapatra
Key managerial personnel or his Key managerial personnel or his Key managerial personnel or his Key managerial personnel or
Nature of related party relationship relative relative relative relative
Description of nature of material
contracts/arrangements/transactions
Professional fee paid Professional fee paid Professional fee paid Professional fee paid
with
related party
Duration of material
contracts/arrangements/transactions
2018-19 2018-19 2018-19 2018-19
with
related party
Dates of approval of material
contracts/arrangements/transactions
28/12/2018 28/12/2018 28/12/2018 28/12/2018
with
related party by board
Amount paid as advances if any for
material
contracts/arrangements/transactions 0 0 0
with
related party

2
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Details of material contracts/arrangements/transactions at arm's length basis [Table] ..(2)


Unless otherwise specified, all monetary values are in INR
Material contracts/arrangements/transactions at
CONTRACTARRANGEMENT5 CONTRACTARRANGEMENT6 CONTRACTARRANGEMENT7
arm's length basis [Axis]
01/04/2018 01/04/2018 01/04/2018
to to to
31/03/2019 31/03/2019 31/03/2019
Name of related party Asima Das Sailaja Jati Prakash Chandra Dalai
Key managerial personnel or his Key managerial personnel or his Key managerial personnel or his
Nature of related party relationship relative relative relative
Details of material
contracts/arrangements/transactions at arm's
length basis [Abstract]
Details of material
contracts/arrangements/transactions at arm's
length basis [LineItems]
Name of related party Asima Das Sailaja Jati Prakash Chandra Dalai
Key managerial personnel or his Key managerial personnel or his Key managerial personnel or his
Nature of related party relationship relative relative relative
Description of nature of material
contracts/arrangements/transactions with Professional fee paid Professional fee paid Professional fee paid
related party
Duration of material
contracts/arrangements/transactions with 2018-19 2018-19 2018-19
related party
Dates of approval of material
contracts/arrangements/transactions with
28/12/2018 28/12/2018 28/12/2018
related party by
board
Amount paid as advances if any for material
0 0 0
contracts/arrangements/transactions with
related party

Details of indebtedness of company [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Secured loans excluding deposits
Indebtedness [Axis] Indebtedness [Member]
[Member]
01/04/2018 01/04/2018
to 31/03/2018 to 31/03/2018
31/03/2019 31/03/2019
Details of indebtedness of company [Abstract]
Details of indebtedness of company [LineItems]
Changes in indebtedness [Abstract]
Addition in indebtedness 11,00,36,572.52 11,00,36,572.52
Reduction in indebtedness 0 0
Total changes in indebtedness 11,00,36,572.52 11,00,36,572.52
Principal amount at end of financial year 15,69,42,000.52 4,69,05,428 15,69,42,000.52 4,69,05,428
Interest due but not paid at end of financial
0 0 0 0
year
Interest accrued but not due at end of
0 0 0 0
financial year
Total indebtedness at end of financial year 15,69,42,000.52 4,69,05,428 15,69,42,000.52 4,69,05,428

3
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Details of directors signing board report [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Directors signing board report [Axis] SIGNATORY1 SIGNATORY2
01/04/2018 01/04/2018
to to
31/03/2019 31/03/2019
Details of signatories of board report [Abstract]
Details of directors signing board report [LineItems]
Name of director signing board report [Abstract]
First name of director MANORANJAN BRUNDABAN
Last name of director MOHAPATRA NAHAK
MANAGING
Designation of director DIRECTOR
CHAIRMAN

Director identification number of director 07493683 03519673


Date of signing board report 07/09/2019 07/09/2019

Details of shareholding pattern [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Shareholding pattern [Axis] Shareholders [Member] Promoters [Member]
01/04/2018 01/04/2018
to 31/03/2018 to 31/03/2018
31/03/2019 31/03/2019
Details of shareholding pattern [Abstract]
Details of shareholding pattern [LineItems]
Number of demat shares held at end of period [shares] 0 [shares] 0 [shares] 0 [shares] 0
Number of physical shares held end of period [shares] 1,63,88,927 [shares] 1,54,91,493 [shares] 1,63,88,927 [shares] 1,54,91,493
Total number of shares held at end of period [shares] 1,63,88,927 [shares] 1,54,91,493 [shares] 1,63,88,927 [shares] 1,54,91,493
Percentage of total shares held at end of period 100.00% 100.00% 100.00% 100.00%
Percentage of change in shares held during year 0.00% 0.00%
Total number of shares held at end of period [shares] 1,63,88,927 [shares] 1,54,91,493 [shares] 1,63,88,927 [shares] 1,54,91,493
Percentage of total shares held at end of period 100.00% 100.00% 100.00% 100.00%
Percentage of change in shares held during year 0.00% 0.00%
Total number of shares held at end of period [shares] 1,63,88,927 [shares] 1,54,91,493 [shares] 1,63,88,927 [shares] 1,54,91,493
Percentage of total shares held at end of
100.00% 100.00% 100.00% 100.00%
period
Total number of shares held at end of period [shares] 1,63,88,927 [shares] 1,54,91,493 [shares] 1,63,88,927 [shares] 1,54,91,493
Percentage of total shares held at end of period 100.00% 100.00% 100.00% 100.00%
Total number of shares held at end of period [shares] 1,63,88,927 [shares] 1,54,91,493 [shares] 1,63,88,927 [shares] 1,54,91,493
Percentage of total shares held at end of
100.00% 100.00% 100.00% 100.00%
period

4
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Details of shareholding pattern [Table] ..(2)


Unless otherwise specified, all monetary values are in INR
Shareholding pattern [Axis] Indian [Member] Individual/HUF [Member]
01/04/2018 01/04/2018
to 31/03/2018 to 31/03/2018
31/03/2019 31/03/2019
Details of shareholding pattern [Abstract]
Details of shareholding pattern [LineItems]
Number of demat shares held at end of period [shares] 0 [shares] 0 [shares] 0 [shares] 0
Number of physical shares held end of period [shares] 1,63,88,927 [shares] 1,54,91,493 [shares] 1,63,88,927 [shares] 1,54,91,493
Total number of shares held at end of period [shares] 1,63,88,927 [shares] 1,54,91,493 [shares] 1,63,88,927 [shares] 1,54,91,493
Percentage of total shares held at end of period 100.00% 100.00% 100.00% 100.00%
Percentage of change in shares held during year 0.00% 0.00%
Total number of shares held at end of period [shares] 1,63,88,927 [shares] 1,54,91,493 [shares] 1,63,88,927 [shares] 1,54,91,493
Percentage of total shares held at end of period 100.00% 100.00% 100.00% 100.00%
Percentage of change in shares held during year 0.00% 0.00%
Total number of shares held at end of period [shares] 1,63,88,927 [shares] 1,54,91,493 [shares] 1,63,88,927 [shares] 1,54,91,493
Percentage of total shares held at end of
100.00% 100.00% 100.00% 100.00%
period
Total number of shares held at end of period [shares] 1,63,88,927 [shares] 1,54,91,493 [shares] 1,63,88,927 [shares] 1,54,91,493
Percentage of total shares held at end of period 100.00% 100.00% 100.00% 100.00%
Total number of shares held at end of period [shares] 1,63,88,927 [shares] 1,54,91,493 [shares] 1,63,88,927 [shares] 1,54,91,493
Percentage of total shares held at end of
100.00% 100.00% 100.00% 100.00%
period

Details of principal business activities contributing 10% or more of total turnover of company [Table] ..(1)
Unless otherwise specified, all monetary values are in INR
Product/service 1
Principal business activities of company [Axis]
[Member]
01/04/2018
to
31/03/2019
Details of principal business activities contributing 10% or more of total turnover of company [Abstract]
Details of principal business activities contributing 10% or more of total turnover of company
[LineItems]
Name of main product/service Hospital Activities
Description of main product/service Hospital Activities
NIC code of product/service 86100
Percentage to total turnover of company 100.00%

5
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Unless otherwise specified, all monetary values are in INR


01/04/2018
to
31/03/2019

Your Directors
have pleasure to present
their 8thAnnual Report
and the Audited Financial
Disclosure in board of directors report explanatory [TextBlock] Statements for the
financial year ended
31stMarch,
2019

Textual information (1)


Description of state of companies affair [See below]
Your company has
transferred an amount of
Profit of Rs.
Disclosure relating to amounts if any which is proposed to carry to any
1,94,39,106.23/- to the
reserves Profit and Loss account
during the year under
review.
Textual information (2)
Disclosures relating to amount recommended to be paid as dividend [See below]
(i) Conservation of
Details regarding energy conservation energy and technology
absorption: Nil
Details regarding technology absorption NIL
(ii) Foreign Exchange
Earnings and Outgo
: (a) Foreign Exchange
Details regarding foreign exchange earnings and outgo Earnings: Nil (Prev. Year
Nil). (b) Foreign
Exchange Outgo: Nil
(Prev. Year Nil).
Textual information (3)
Disclosures in director’s responsibility statement [See below]
Details of material changes and commitment occurred during period
NA
affecting financial position of company
Textual information (4)
Particulars of loans guarantee investment under section 186 [TextBlock] [See below]
Particulars of contracts/arrangements with related parties under section Textual information (5)
188(1) [TextBlock] [See below]
Whether there are contracts/arrangements/transactions not at arm's
No
length basis
Whether there are material contracts/arrangements/transactions at
Yes
arm's length basis
Disclosure of extract of annual return as provided under section 92(3) Textual information (6)
[TextBlock] [See below]
Details of change in promoters shareholding [TextBlock]
Details of shareholding pattern of directors and key managerial
personnel [TextBlock]
Disclosure of statement on declaration given by independent directors
NA
under section 149(6) [TextBlock]

There was no
Disclosure for companies covered under section 178(1) on change in the board of
directors appointment and remuneration including other matters directors of the company
provided under section 178(3) [TextBlock] during the year under
review.

Disclosure of statement on development and implementation of risk Textual information (7)


management policy [TextBlock] [See below]
Details on policy development and implementation by company on
corporate social responsibility initiatives taken during year NA
[TextBlock]

Disclosure as per rule 8(5) of companies accounts rules 2014 [TextBlock] AS

Textual information (8)


Disclosure of financial summary or highlights [TextBlock] [See below]

6
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

There is no
Change in the nature of the
Disclosure of change in nature of business [TextBlock] business of the Company
during the
year.

N o t
Applicable
Details of directors or key managerial personnels who were
appointed or have resigned during year [TextBlock]

Disclosure of companies which have become or ceased to be its


subsidiaries, joint ventures or associate companies during NIL
year [TextBlock]
Details relating to deposits covered under chapter v of companies act
NIL
[TextBlock]
Deposits accepted during year 0
Deposits remained unpaid or unclaimed at end of year 0
Amount of default in repayment of deposits or payment of interest
0
thereon beginning of year
Maximum amount of default in repayment of deposits or payment of
0
interest thereon during year
Amount of default in repayment of deposits or payment of interest
0
thereon end of year
Number of cases of default in repayment of deposits or payment
0
of interest thereon beginning of year
Maximum number of cases of default in repayment of deposits or
0
payment of interest thereon during year
Number of cases of default in repayment of deposits or payment
0
of interest thereon end of year
Details of deposits which are not in compliance with requirements
NA
of chapter v of act [TextBlock]
Details of significant and material orders passed by
regulators or courts or tribunals impacting going concern NIL
status and company’s operations in future [TextBlock]
Details regarding adequacy of internal financial controls with Textual information (9)
reference to financial statements [TextBlock] [See below]

Disclosure of appointment and remuneration of managerial personnels N o t


[TextBlock] Applicable

Number of meetings of board 6

Textual information (1)

Description of state of companies affair


RESULTS OF OPERATION AND THE STATE OF COMPANY'S AFFAIRS: This is the fifth year of commercial operation of hospital
activities of your company, which was started during the year, 2014-15 from a rented building situated at Nayapalli, Bhubaneswar. It is a super
specialty care hospital in Gastroenterology and Kidney diseases. The hospital has the state-of-art technology with all the modern facility including
forty beds and two modular Operation Theaters with advance modern equipment, CT scan unit, Canteen facility with 200 trained staff. It has
achieved total revenue of about Rs. 18.60 crores during the fifth year of operation as against a turnover of Rs. 17.70 Crores during the preceding
year resulting in a growth of 5.65% over the previous year. During this fifth year of operation the company has earned a profit of Rs. 269.91 lakhs
as against Rs. 195.67 lakhs having a bottom-line growth of 37.94% on account of reduced Business Development expenses and expenses towards
Travelling & Conveyance and lesser depreciation. Your directors are hopeful that there would be significant growth in the revenue and earnings
as well in the following years to come. FUTURE OUTLOOK: Your company is in the advance stage of setting up a Super Specialist Gastro and
Kidney Care Hospital buildings on the contiguous land measuring 2.5 Ac. dec. situated at Kalinga Nagar, Ghatikia, Bhubaneswar allotted by the
Government of Odisha. The structural work of the existing new building and the additional building as well has been completed and the interior
work is in the progress. Your company has already spent an amount of Rs. 35.87 Crores towards the construction of the new hospital buildings
the company endeavors to finish the buildings by end of the year, 2019-20 which is in the advance stage and make it operational in April, 2020.
The Hospital will have the state of art technology with all super specialist doctors in the field of Gastro & Renal diseases. The Hospital will have
the facilities of 200 Bed, 6 nos. of Operation Theaters including Ino Robotic OT, ICU of 50 beds, Dialysis unit of 20 beds, OPD of 20 chambers, a
dedicated liver & kidney transplant unit with laser lithotripsy, 3 nos. of advance endoscopy suits for ERCP, EUS, Enteroscopy, a Blood Bank,
CSSD, Laundry and a Research Laboratory. The cost of the said project has been pegged at Rs. 120.84 Crores with a promoter's contribution of
Rs. 40.84 Crores and borrowing of Rs. 80 Crores. Your company has received necessary sanction letters from SBI, Bhubaneswar for a Term Loan
of Rs. 45 Crores and PNB, Bhubaneswar for a Term Loan of Rs. 35 Crores for the said Project as envisaged. Your management has the vision of
becoming a leader in the field of gastro and kidney disease with a special emphasis for liver and kidney transplantation.

7
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (2)

Disclosures relating to amount recommended to be paid as dividend


As your management wish to conserve its resources and to utilize the same for the purpose of establishing the Super Specialist Hospital, it did not
propose to pay any dividend for the year under review.

Textual information (3)

Disclosures in director’s responsibility statement


Pursuant to provisions under section 134(5) of the Companies Act, 2013, your Directors hereby confirm: i) that in the preparation of the annual
accounts for the financial year ended 31st March, 2019, the applicable accounting standards read with requirements set out under schedule III of
the Companies Act, 2013 have been followed and there are no material departures from the same; ii) that they have selected such accounting
policies and applied them consistently and made judgments and estimates that were reasonable and prudent so as to give a true and fair view of
the state of affairs of the Company at the end of the financial year and of the profit for the year under consideration; iii) that they have taken
proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act, 2013 for
safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities; iv) that they have prepared the annual
accounts of the Company for the financial year ended 31st March, 2019 on a going concern basis; v) that they have laid down internal financial
controls to be followed by the company and that such internal financial controls are adequate and were operating effectively; vi) that they had
devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating
effectively.

Textual information (4)

Particulars of loans guarantee investment under section 186 [Text Block]


Your Company has not given any Loans, Guarantees and Investments covered under the provisions of Section 186 of the Companies Act, 2013.

Your company has not accepted any deposits from public as envisaged under Section 73 to 76 of the Companies Act, 2013 read with Companies
(Acceptance of Deposits) Rules, 2014.

8
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (5)

Particulars of contracts/arrangements with related parties under section 188(1) [Text Block]
The directors of the company, who are professionally qualified doctors including their relatives, have received an aggregate amount of Rs.
3,56,20,065/- towards their professional fees and Rs. 86,00,000/- towards remuneration during the year under review. Form No. AOC-2, which
forms part of the Directors' Report, is annexed to this report. .

FORM NO. AOC-2

[Pursuant to clause (h) of sub-section (3) of 134 of the Act and Rule 8(2) of the Companies (Accounts) Rules, 2014]

Form for Disclosure of particulars of contracts/arrangements entered into by the company with related parties referred to in sub section (1) of
Section 188 of the Companies Act, 2013 including certain arms length transaction under third proviso thereto.

1. Details of Contracts or arrangements or transactions not at Arm's length basis.

SI.
Particulars Details
No.

Name(s) of the related party & nature of relationship

Nature of Contracts/arrangements/transaction

No such contracts or arrangements or


Salient terms of the contracts or arrangements or transaction including the value, if any
transactions

Justification for entering into such contracts or arrangements or transactions'

Date of approval by the Board

Amount paid as advance, if any

Date on which the special resolution was passed in General meeting as required under first
proviso to Section 188

2. Details of Contracts or arrangements or transactions at Arm's length basis and in the ordinary course of business.

SI. No. Particulars Details

9
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Dr. Kedarnath Panda,


01 Name(s) of the related party & nature of relationship
Managing Director

Nature of Contracts/arrangements/transaction Professional fee paid

Duration of the contracts/ arrangements/ transaction 2018-19

Salient terms of the contracts or arrangements or transaction including the value, if any Rs. 1,32,52,244/-

Date of approval by the Board 28/12/2018

Amount paid as advance, if any Nil

Particulars Details
SI. No.

02 Name(s) of the related party & nature of relationship Dr. Subodh Das, Director

Nature of Contracts/ arrangements/ transaction Professional fee paid

Duration of the contracts/ arrangements/ transaction 2018-19

Salient terms of the contracts or arrangements or transaction including the value, if any Rs. 27,50,327/-

Date of approval by the Board 28/12/2018

Amount paid as advance, if any Nil

10
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

SI. No. Particulars Details

03 Name(s) of the related party & nature of relationship Dr. Prakash Chandra Dalai, Director

Nature of Contracts/ arrangements/ transaction Professional fee paid

Duration of the contracts/ arrangements/ transaction 2018-19

Salient terms of the contracts or arrangements or transaction including the value, if any Rs. 1,30,23,944/-

Date of approval by the Board 28/12/2018

Amount paid as advance, if any Nil

SI. No. Particulars Details

04 Name(s) of the related party & nature of relationship Dr. Brundaban Nahak, Director

Nature of Contracts/ arrangements/ transaction Professional fee paid

Duration of the contracts/ arrangements/ transaction 2018-19

Salient terms of the contracts or arrangements or transaction including the value, if any Rs. 28,27,640/-

Date of approval by the Board 28/12/2018

Amount paid as advance, if any Nil

SI. No. Particulars Details

05 Name(s) of the related party & nature of relationship Dr. Manoranjan Mohapatra, Director

Nature of Contracts/ arrangements/ transaction Professional fee paid

11
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Duration of the contracts/ arrangements/ transaction 2018-19

Salient terms of the contracts or arrangements or transaction including the value, if any Rs. 33,00,670/-

Date of approval by the Board 28/12/2018

Amount paid as advance, if any Nil

SI. No. Particulars Details

06 Name(s) of the related party & nature of relationship Dr. Asima Das

Nature of Contracts/ arrangements/ transaction Professional fee paid

Duration of the contracts/ arrangements/ transaction 2018-19

Salient terms of the contracts or arrangements or transaction including the value, if any Rs. 15,240/-

Date of approval by the Board 28/12/2018

Amount paid as advance, if any Nil

SI. No. Particulars Details

07 Name(s) of the related party & nature of relationship Smt.Sailaja Jati

Nature of Contracts/ arrangements/ transaction Professional fee paid

Duration of the contracts/ arrangements/ transaction 2018-19

Salient terms of the contracts or arrangements or transaction including the value, if any Rs. 4,50,000/-

Date of approval by the Board 28/12/2018

Amount paid as advance, if any Nil

12
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (6)

Disclosure of extract of annual return as provided under section 92(3) [Text Block]
Form No. MGT-9

EXTRACT OF ANNUAL RETURN

As on the Financial Year ended on 31stMarch, 2019

[Pursuant to Section 92(3) of the Companies Act, 2013 and Rule 12(1) of the Companies (Management and Administration) Rules, 2014]

I. REGISTRATION AND OTHER DETAILS:-

i)CIN-: U 8 5 1 1 0 O R 2 0 1 1 P T C 0 1

3 8 0 3

ii) Registration Date 2 3 - 0 6 - 2 0 1 1

iii) Name of the Company-: I N S T I T U T E O F G A S T R O

A N D K I D N E Y C A R E

P R I V A T E L I M I T E D

iv) Category/ Sub-Category of the Company-:

(a) Category of the Company:- [pl. Tick]

1. Public Company ( )

13
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

2. Private Company ( v )

(b) Sub-Category of the Company:- {Please tick whichever are applicable}

1. Government Company ( )

2. Small Company ( )

3. One Person Company ( )

4. Subsidiary of Foreign Company ( )

5. NBFC ( )

6. Guarantee Company ( )

7. Limited By Share (v )

8. Unlimited Company ( )

9. Company having Share Capital ( v )

10. Company not having Share Capital ( )

11. Company Registered under Section-8 ( )

v) Address of the Registered Office and Contract details-:

Address P L O T N O - 1 4 6 0 / 6 1

N - 1 , I R C V I L L A G E

N A Y A P A L L I

Town/ City B H U B A N E S W A R

14
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

State O D I S H A Pin Code 7 5 1 0 1 5

Telephone with STD 0 6 7 4 2 5 5 3 3 3 4

Area Code Number

Fax Number

E-Mail Address i g k c h o s p i t a l @ g m a i l . c o m

Web Site:

vi) Whether listed company-: No

vii) Name, address, and contract details of registrar and transfer agent, if any-: N.A.

Name

Address

Town/ City

15
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

State Pin Code

Telephone with STD

Area Code Number

Fax Number

E-Mail Address

II.PRINCIPAL BUSINESS ACTIVITIES OF THE COMPANY-:

All the business activities contributing 10% or more of the total turnover of the company shall be stated:-

SL No. Name and Description of Main Products/ Services NIC Code of the Product/ Services % to total turnover of the company

1. Hospital Activities 86100 100

III.PARTICULARS OF HOLDING, SUBSIDIARY AND ASSOCIATE COMPANIES:-

Sl. No. Name and Address of the Company CIN/GLN Holding/ Subsidiary/ Associate % of Shares Held Applicable Section

-
1. - - - -

-
2. - - - -

16
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

IV. SHARE HOLDING PATTERN (Equity Share Capital Break up as Percentage of

Total Equity)

i) Category wise Share Holding-:

No of Shares No. of Shares


% change
held at the held at the
Category of Share Holders during the
beginning of end of the
year
the year year

% of
Dem Total
% of % of Share
Demat Physical Total Total at Physical Total total
Shares Shares

A. Promoters

(1) Indian

a) Individual/ HUF

b) Central Govt.

c) State Govt.

d) Bodies corp.
15491493 15491493
16388927 16388927
e) Banks/FI 100 - 100
- - -
f) Any Other
- - - -
- - -
-
Sub-total
- -

17
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

- - - - - -
(A) (1)
- -
- - - - - -
- -
(2)Foreign
- - - - - -
- -
- - - - - -
(a) NRIs-
16388927 16388927
Individuals
15491493 15491493 100 - 100 -
(b)Other

Individuals
- -
- - - - - -
(c)Bodies
- -
Corp.
- - - - - -
(d)Banks/FI
- -
- - - - - -
(e)Any other
- -
- - - - - -
Sub-Total
- -
- - - - - -
(A) (2):-
- -
- - - - - -
Total Share Holding of Promoter (A)=
(A)(1)+(A)(2)
- -
- - - - - -
B. Public Shareholding
16388927 16388927
15491493 15491493 100 - 100 -
(1)Institutions

(a)Mutual

Funds
- -
(b)Banks/FI
- - - - - -
(c)Central
- -
- - - - - -
Govt
- -
- - - - - -
(d)St (d) State
- -
Govt(s)
- - - - - -
(e) Venture
- -
- - - - - -
Capital

Funds (f)Insurance
- -
- - - - - -
Companies
- -
(g) FIIS
- - - - - -
- -
(h) Foreign
- - - - - -
Venture
- -
Capital funds
- - - - - -
(j)Others
- -

18
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

(Specify) - - - - - -

Sub- Sub-Total (B) (1):-


- -
- - - - - -
2.Non-
- -
Institution (a)Bodies - - - - - -

corporate
- -
i)Indian
- - - - - -
(ii) Overseas (b)Individuals

(i) Individual

Shareholders
- -
Holding - - - - - -

nominal

share capital up to Rs.1 lakh

- -
(ii)Individual Share holders
holding nominal share capital in excess of - - - - - -
Rs. 1 Lakh.

c)Others (Specify)
- -
- - - - - -
Sub- Total(B)(2):-Total public Shareholding
- -
(B)=(B)(1)+(B)(2)
- - - - - -

(C)Shares
16388927 16388927
Held by Nil
15491493 15491493 100 - 100
Custodian for

GDR & ADRs

Grand Total (A+B+C)

(ii)Share holding of Promoters

Sr Share holder's Share holding at the Share holding at the


No Name beginning of the year end of the period

% of shares
% of Shares pledged/
Pledged/ % changes in share
% of total Share of No of % of total shares
No of shares holding during the
the Company shares of the company encumber
encumber to to total year

19
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

total shares share

Kedar Nath
1 35,72,488 23.06 - 37,39,154 22.82 - (0.24)
Panda

Brudaban
2 29,97,222 19.35 - 31,25,427 19.07 - (0.28)
Nahak

Subodh
3 31,47,222 20.32 - 33,13,888 20.22 - (0.10)
Kumar Das

Sukanto
4. 3,13,555 2.02 - 4,41,760 2.70 - 0.68
Kishore Das

Prakash
5. 27,05,888 17.47 - 28,34,093 17.30 - (0.17)
Chandra Dalai

Nitish Kumar
6. 8,000 0.05 - 8,000 0.05 - -
Mohanty

Manoranjan
7. 8,69,444 5.61 - 10,23,290 6.24 - (0.63)
Mohapatra

Kshistish
8. Chandra 4,44,444 2.87 - 4,44,444 2.71 - (0.16)
Mishra

Rabindranath
9. 3,66,600 2.37 - 3,66,600 2.24 - (0.13)
Tripathy

Amulya
10. 4,11,077 2.65 - 4,36,718 0.86 - (1.79)
Kumar Panda

Pradeep
11. Kumar 1,41,666 0.91 - 1,41,666 2.66 - 1.75
Mishra

Abhay Kumar
12. 2,77,777 1.79 - 2,77,777 1.69 - (0.10)
Sahoo

Laxmidhar
13. 69,444 0.45 - 69,444 0.42 - (0.03)
Parhi

Jitendra
14. 1,66,666 1.08 - 1,66,666 1.02 - (0.06)
Kumar Panda

Total 1,54,91,493 100 - 1,63,88,927 100 - (1.26)

20
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

(iii) Changes in Promoters' Shareholding (Please specify, if there is no change)

Sl Share holding at the Cumulative Share holding


No. beginning of the period during the year

% of total shares of the No of each % of total shares of


FOR EACH OF THE Promoters during the year No of Shares
company shares the company

1,54,91,493 1,54,91,493
At the beginning of the year 100 100

Date wise Increase in shareholding during the year


by allotment of equity shares
-
1. Allotment of shares on 17/05/2018
8,97,434 1,63,88,927 -

At the end of the year (or on the date of separation, 1,63,88,927 1,63,88,927
100 100
if separated during the year

V) Share Holding Pattern of the Top Ten Shareholders (other than Directors, Promoters and Holders of GDRs and ADRs):-

Sl Share holding at the Cumulative Share


No. beginning of the period holding the year

% of total shares of No of each % of total shares of


FOR EACH OF THE TOP TEN SHARE HOLDERS No of Shares
the company shares the company

At the beginning of the year - - - -

Date wise Increase/ Decrease in shareholding during


the year specifying the reason for

Decrease by way of transfer


- - -
/transmission/redemption/buy back of Shares -

At the end of the year (or on the date of separation, if


- - - -
separated during the year

(VI) Shareholding of Directors and Key Managerial Personnel:-

Sl Share holding at the Cumulative Share


No. beginning of the period holding during the year

21
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

FOR EACH OF THE Directors / Key Managerial % of total shares of the No of each % of total shares
No of Shares
Person company shares of the company

1,32,92,264 1,32,92,264
At the beginning of the year 81.10 81.10

Date wise Increase/ Decrease in shareholding during


the year specifying the reason for

7,43,588
4.54 1,40,35,852
1. Increase by way of allotment of Equity Shares on
17/05/2019 4.54

At the end of the year (or on the date of separation, if 1,40,35,852


85.64 1,40,35,852 85.64
separated during the year

VII. INDEBTNESS-:

Indebtedness of the company including interest outstanding/ accrued but not due for payment

Secured loans excluding deposits Unsecured loans Deposits Total Indebtness

Indebtness at the beginning of the financial year

1) Principal Amount

2)Interest due but 4,69,05,428.00 - - 4,69,05,428.00

not paid - - - -

3)Interest accrued
- - - -

22
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

but not due

Total (1+II+III) 4,69,05,428.00 - - 4,69,05,428.00

Change in indebtedness during the financial year

� Addition
- -
11,00,36,572.52 11,00,36,572.52 -
� Reduction
- -

Net change 11,00,36,572.52 - - 11,00,36,572.52

Indebtedness at the end of the financial year


15,69,42,000.52
15,69,42,000.52
- -
1) Principal amount
-
2) Interest due but not Paid
- -
-
3) Interest accrued but not due
-
- -
-

15,69,42,000.52 15,69,42,000.52
Total (i+ii+iii) - -

VIII. REMUNERATION OF DIRECTORS AND KEY MANAGERIAL PERSONNEL

A. Remuneration to Managing Director, whole-time and/or Manager:-

Sl. No. Particulars of Remuneration Name of MD/WTD/Manager Total amount

Kedar Nath Panda

(Managing Director)
In Rs.
In Rs.

Gross salary

23
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

(a) Salary as per

provisions contained

in section 17(1) of 48,00,000.00 48,00,000.00

the Income-tax

Act, 1961

1.
(b) Value of perquisites u/s
- -
17(2) Income- tax Act,

1961

- -
(c) Profits in lieu of salary

under 17(3) Income-

tax Act, 1961

2.
Stock Option - -

3.
Sweat Equity - -

Commission

- as % of profit
- -
4.
- others, specify
- -

5.
Others, Professional Fees 1,32,52,244.00 1,32,52,244.00

Total (A) 1,80,52,244.00 1,80,52,244.00

Ceiling as per the Act

B. Remuneration to other directors-:

Total Amount
Sl. No Particulars of Remuneration Name of Directors

24
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

In Rs.

Brundaban Nahak Subodh Kumar Das Prakash Chandra Dalai

(In Rs.) (In Rs.) (In Rs.)

1. Independent Directors

- - - -
(a) Fee for attending board committee meetings

(b) Commission
- - - -
(c) Others, please specify
- - - -

Total (1)
- - - -

2. Other Non- Executive Directors

(a) Fee for attending board committee meetings


- - - -
(b) Commission
- - - -
(c) Others, Salary
7,00,000 7,00,000 12,00,000 26,00,000
(d) Professional Fees
28,27,640 27,50,327 1,30,23,944 1,86,01,911

Total (2)
35,27,640 34,50,327 1,42,23,944 2,12,01,911

Total (B) =(1+2)


35,27,640 34,50,327 1,42,23,944 2,12,01,911

Total Managerial Remuneration

Overall Ceiling as per the Act

Remuneration to other directors-:

Sl. No. Particulars of Remuneration Name of Directors Total Amount

25
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Manoranjan Mohapatra Sujata Tripathy

1. Independent Directors

- - -
(d) Fee for attending board committee meetings

(e) Commission
- - -
(f) Others, please specify
- - -

Total (1) - - -

2. Other Non- Executive Directors

(e) Fee for attending board committee meetings -


- -
(f) Commission
-
- -
(g) Others, salary
6,00,000
6,00,000 12,00,000
(h) Professional fee
-
33,00,670 33,00,670

Total (2) 39,00,670 6,00,000 45,00,670

Total (B) =(1+2) 39,00,670 6,00,000 45,00,670

Total Managerial Remuneration

Overall Ceiling as per the Act

C. REMUNERATION TO KEY MANAGERIAL PERSONNEL OTHER THAN MD/MANAGER/ WTD-:

Sl Key Managerial
Particulars of Remuneration
No Personnel

26
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Company Secretary Padma Charan Total


Panda
Sujata Behera
CEO
(Chief Financial
From Officer)
(01/01/2019-31/03/2019) In Rs.
In Rs.

5,92,500 6,07,500

Gross Salary

(a) Salary as per provisions contained in section17(1) of the


income Tax Act, 1961
15,000
1.
(b) Value of perquisites U/s17(2) Income Tax Act,1961
- -
(c) Profit in lieu of salary under section 17(3) of Income Tax
Act, 1961

- -

-
2. Stock Option -

3. Sweat Equity - -

Commission

4. -as % of profit - -

-Others, specify

5. Others please specify - -

5,92,500 6,07,500
Total 15,000

IX. PENALITIES/ PUNISHMENT/ COMPUNDING OF OFFENCES:- Nil

Authority
Details of Penalty/
Section of the Companies Brief Appeal made, if any Give
TYPES [RD/NCLT/
Act Description punishment/ compounding fees Details)
imposed
Court]

A. Company

27
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Penalty - - - - -

Punishment - - - - -

Compounding - - - - -

B. Directors

Penalty - - - - -

Punishment - - - - -

C. Other Officer in
Default

Penalty - - - - -

Punishment - - - - -

Compounding - - - - -

Textual information (7)

Disclosure of statement on development and implementation of risk management policy [Text Block]
The company identifies and assesses various risks related to key business and strategic objectives. All the identified risks are monitored and
addresses regularly based on their severity impact and all major risks are systematically mitigated and reviewed on a continuous basis

28
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (8)

Disclosure of financial summary or highlights [Text Block]

Particulars 2018-19 2017-18

Revenue from operation 18,33,13,629.07 17,21,50,120.01

Other Income 26,83,667.08 48,40,937.97

Total Revenue 18,59,97,296.15 17,69,91,057.98

Profit/(Loss) before interest & depreciation 3,45,47,643.99 3,06,72,314.21

Finance Cost 7,90,748.76 7,54,594.40

Depreciation 67,65,776.00 1,03,50,686.00

Profit/(Loss) before Tax 2,69,91,119.23 1,95,67,033.81

Deferred Tax liability/(asset) (27,932.00) (1,91,350.00)

Provision for Tax 75,79,945.00 56,32,799.00

Profit/(loss) after Tax 1,94,39,106.23 1,41,25,584.81

Proposed Dividend (Including Tax on Dividend) - -

Balance c/f to Profit and Loss Account 1,94,39,106.23 1,41,25,584.81

Textual information (9)

Details regarding adequacy of internal financial controls with reference to financial statements [Text Block]
The Company has in place adequate internal financial control with reference to financial statement. During the year under review, such controls
were tested and no reportable material weaknesses in the design or operation were observed.

29
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[400200] Disclosures - Auditors report

Details regarding auditors [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Auditors [Axis] AUDITOR
01/04/2018
to
31/03/2019
Details regarding auditors [Abstract]
Details regarding auditors [LineItems]
Category of auditor Auditors firm
A B P S &
Name of audit firm ASSOCIATES
SENAPATI
Name of auditor signing report SURENDRA
KUMAR
Firms registration number of audit firm 324706E
Membership number of auditor 400016
182, SAHEED
NAGAR, BEHIND
ALOK BHARATI T
Address of auditors O W E R ,
BHUBANESWAR,
ODISHA-751007
Permanent account number of auditor or auditor's firm AADFN2530P
SRN of form ADT-1 H18072074
Date of signing audit report by auditors 07/09/2019
Date of signing of balance sheet by auditors 07/09/2019

30
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of auditor's qualification(s), reservation(s) or adverse remark(s) in auditors' report [Table] ..(1)
Unless otherwise specified, all monetary values are in INR
Auditor's
Auditor's qualification(s), reservation(s) or adverse remark(s) in auditors' report [Axis] favourable remark
[Member]
01/04/2018
to
31/03/2019
Disclosure of auditor's qualification(s), reservation(s) or adverse remark(s) in auditors' report [Abstract]
Disclosure of auditor's qualification(s), reservation(s) or adverse remark(s) in auditors' report
[LineItems]
(i) In respect of its
Disclosure in auditors report relating to fixed assets fixed assets:
(a) The Company
has maintained
proper records
showing full
Disclosure relating to quantitative details of fixed assets particulars, including
quantitative details
and situation of fixed
assets.
Textual information
Disclosure relating to physical verification and material discrepancies of fixed assets (10) [See below]
Textual information
Disclosure relating to title deeds of immovable properties (11) [See below]
Textual information
Disclosure in auditors report relating to inventories (12) [See below]
Textual information
Disclosure in auditors report relating to loans (13) [See below]
Disclosure about loans granted to parties covered under section 189 of companies act NA
Disclosure relating to terms and conditions of loans granted NA
Disclosure regarding receipt of loans granted NA
Disclosure regarding terms of recovery of loans granted NA
Textual information
Disclosure in auditors report relating to compliance with Section 185 and 186 of Companies Act, 2013 (14) [See below]
Textual information
Disclosure in auditors report relating to deposits accepted (15) [See below]
Textual information
Disclosure in auditors report relating to maintenance of cost records (16) [See below]
Textual information
Disclosure in auditors report relating to statutory dues [TextBlock] (17) [See below]
Textual information
Disclosure relating to regularity in payment of undisputed statutory dues [TextBlock] (18) [See below]
Textual information
Disclosure relating to disputed statutory dues [TextBlock] (19) [See below]
(viii) In our opinion
and according to the
information and
explanations given
to us, the Company
Disclosure in auditors report relating to default in repayment of financial dues has not defaulted in
the repayment of
dues to financial
institutions, banks
and debenture
holders
Disclosure in auditors report relating to public offer and term loans used for purpose for which Textual information
those were raised (20) [See below]
Disclosure in auditors report relating to fraud by the company or on the company by its officers Textual information
or its employees reported during period (21) [See below]
Textual information
Disclosure in auditors report relating to managerial remuneration (22) [See below]
(xii) In our opinion
and according to the
information and
explanations given
to us, the Company
Disclosure in auditors report relating to Nidhi Company is not a nidhi
company.
Accordingly,
paragraph 3(xii) of
the Order is not
applicable.
Textual information
Disclosure in auditors report relating to transactions with related parties (23) [See below]

31
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure in auditors report relating to preferential allotment or private placement of shares or Textual information
convertible debentures (24) [See below]
Disclosure in auditors report relating to non-cash transactions with directors or persons connected Textual information
with him (25) [See below]
(xvi) The Company
is not required to be
Disclosure in auditors report relating to registration under section 45-IA of Reserve Bank of India registered under
Act, 1934 section 45-IA of the
Reserve Bank of
India Act 1934

Unless otherwise specified, all monetary values are in INR


01/04/2018
to
31/03/2019
Textual information (26)
Disclosure in auditor’s report explanatory [TextBlock] [See below]
Whether companies auditors report order is applicable on company Yes
Whether auditors' report has been qualified or has any reservations or
No
contains adverse remarks

Textual information (10)

Disclosure relating to physical verification and material discrepancies of fixed assets


(b) As explained to us, all the fixed assets have been physically verified by the Management in a phased periodical manner, which in our opinion
is reasonable having regard to the size of the Company and nature if its business. No material discrepancies were noticed on such verification

Textual information (11)

Disclosure relating to title deeds of immovable properties


(c) According to the information and explanations given to us, the records examined by us, we report that the Company does not hold any
freehold immovable property in the name of the Company as at the balance sheet date. In respect of immovable properties of land that have been
taken on lease and disclosed as fixed assets in the financial statements, the lease agreements are in the name of the Company

Textual information (12)

Disclosure in auditors report relating to inventories


(ii) In respect of its inventories: (a) As explained to us, the inventories were physically verified during the year by the Management at reasonable
intervals. (b) In our opinion and according to the information and explanations given to us, the procedures of physical verification of inventories
followed by the Management were reasonable and adequate in relation to the size of the Company and the nature of its business. (c) In our
opinion and according to the information and explanations given to us, the Company has maintained proper records of its inventories and no
material discrepancies were noticed on physical verification.

Textual information (13)

Disclosure in auditors report relating to loans


According to the information and explanation given to us and on the basis of our examination of the books of account, the Company has not
granted any loans, secured or unsecured, to companies, firms or other parties covered in the Register maintained under Section 189 of the
Companies Act, 2013

Textual information (14)

Disclosure in auditors report relating to compliance with Section 185 and 186 of Companies Act, 2013
(iv) In our opinion and according to information and explanation given to us, the company has not granted any loans or provided any guarantees
or given any security or made any investments to which the provision of section 185 and 186 of the Companies Act, 2013. Accordingly,
paragraph 3 (iv) of the order is not applicable.

32
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (15)

Disclosure in auditors report relating to deposits accepted


(v) According to the information and explanations given to us and on the basis of our examination of the books of account, the Company has not
accepted any deposit during the year. Therefore, the provision of clause-3(v) is not applicable to the company

Textual information (16)

Disclosure in auditors report relating to maintenance of cost records


(vi) The maintenance of cost records pursuant to the Companies (Cost Records and Audit) Rules, 2014, as amended and prescribed by the Central
Government under sub-section (1) of Section 148 of the Companies Act, 2013 are not applicable to the Company

Textual information (17)

Disclosure in auditors report relating to statutory dues [Text Block]


The Company has generally been regular in depositing undisputed statutory dues, including Provident Fund, Employees' State Insurance,
Income-tax, Goods and Service Tax, Value Added Tax, Cess and other material statutory dues applicable to it with the appropriate authorities

Textual information (18)

Disclosure relating to regularity in payment of undisputed statutory dues [Text Block]


There were no undisputed amounts payable in respect of Provident Fund, Employees' State insurance, Income-tax, Sales Tax, Wealth Tax,
Service Tax, Customs Duty, Excise Duty, Value Added Tax, Cess and other material statutory dues in arrears as at 31stMarch 2019 for a period
of more than six months from the date they became payable.

Textual information (19)

Disclosure relating to disputed statutory dues [Text Block]


According to the information and explanations given to us and the records of the company examined by us, there are no dues of income-tax, sales-
tax, service tax, goods and service tax, duty of customs, duty of excise and value added tax which have not been deposited on account of any
dispute

Textual information (20)

Disclosure in auditors report relating to public offer and term loans used for purpose for which those were raised
(ix) In our opinion and according to the information and explanations given to us, the Company raised money by way of term loan and further
issue of share capital were applied for the purpose for which they were raised

Textual information (21)

Disclosure in auditors report relating to fraud by the company or on the company by its officers or its employees
reported during period
(x) To the best of our knowledge and according to the information and explanations given to us, no fraud by the Company and no material fraud
on the Company has been noticed or reported during the year

33
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (22)

Disclosure in auditors report relating to managerial remuneration


(xi) As the provision of Sec-197 read with Schedule-V is not applicable to Private companies, the Company has paid/provided for managerial
remuneration after considering the factors such as:-qualification, experience and performance of Directors

Textual information (23)

Disclosure in auditors report relating to transactions with related parties


According to the information and explanation given to us and based on our examination of the records of the Company, transactions with the
related parties are in compliance with sections 177 and 188 of the Act where applicable and details of such transactions have been disclosed in the
financial statements in Note-23 as required by the applicable accounting standard.

Textual information (24)

Disclosure in auditors report relating to preferential allotment or private placement of shares or convertible
debentures
According to the information and explanations give to us and based on our examination of the records of the Company, the Company has made
private placement of 8,97,434 Nos. equity shares of `10/- each at a premium of `29/- per share during the year

Textual information (25)

Disclosure in auditors report relating to non-cash transactions with directors or persons connected with him
(xv) According to the information and explanations given to us and based on our examination of the records of the Company, the Company has
not entered into non-cash transactions with directors or persons connected with him. Accordingly, paragraph 3(xv) of the Order is not applicable

34
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (26)

Disclosure in auditor’s report explanatory [Text Block]


Report on the audit of Financial Statements

Opinion

We have audited the accompanying financial statements of INSTITUTE OF GASTRO & KIDNEY CARE PRIVATE LIMITED ("the
Company"), which comprise the balance sheet as at March 31, 2019, the Statement of Profit and Loss and statement of cash flows for the year
then ended, and notes to the financial statements, including a summary of significant accounting policies and other explanatory information.

In our opinion and to the best of our information and according to the explanations given to us, the aforesaid financial statements give the
information required by the Companies Act, 2013 ('Act') in the manner so required and give a true and fair view in conformity with the
accounting principles generally accepted in India, of the state of affairs of the Company as at March 31, 2019, its profit and cash flows for the
year ended on that date.

Basis for Opinion

We conducted our audit in accordance with the standards on auditing specified under section 143 (10) of the Companies Act, 2013. Our
responsibilities under those Standards are further described in the auditor's responsibilities for the audit of the financial statements section of our
report. We are independent of the Company in accordance with the code of ethics issued by the Institute of Chartered Accountants of India
together with the ethical requirements that are relevant to our audit of the financial statements under the provisions of the Act and the rules there
under, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the code of ethics.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Management's Responsibility for the Financial Statements

The Company's Board of Directors is responsible for the matters stated in Section 134(5) of the Companies Act, 2013("the Act") with respect to
the preparation of these financial statements that give a true and fair view of the financial position, financial performance and Cash Flow of the
Company in accordance with the accounting principles generally accepted in India, including the Accounting Standards specified under Section
133 of the Act, read with Rule 7 of the Companies (Accounts) Rules, 2014.

This responsibility also includes the maintenance of adequate accounting records in accordance with the provision of the Act for safeguarding of
the assets of the Company and for preventing and detecting the frauds and other irregularities; selection and application of appropriate accounting
policies; making judgments and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal
financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the
preparation and presentation of the financial statements that give a true and fair view and are free from material misstatement, whether due to
fraud or error.

In preparing the Financial statements, Management is responsible for assessing the company's ability to continue as going concern, disclosing, as
applicable, matters related to Going concern and using the going concern basis of accounting unless management either intends to liquidate to the
company or to cease the operations, or has no realistic alternative but to do so.

The Board of Director's are also responsible for overseeing the company's financial reporting process.

35
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Auditor's Responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether
due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a
guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from
fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic
decisions of users taken on the basis of these financial statements.

As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We
also:

Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit
procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not
detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery,
intentional omissions, misrepresentations, or the override of internal control. Obtain an understanding of internal control relevant to the audit in
order to design audit procedures that are appropriate in the circumstances. Under section 143(3)(i) of the Companies Act, 2013, we are also
responsible for expressing our opinion on whether the company has adequate internal financial controls system in place and the operating
effectiveness of such controls Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related
disclosures made by management. Conclude on the appropriateness of management's use of the going concern basis of accounting and, based on
the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's
ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to
the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the
audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the company to cease to continue as
a going concern. Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the
financial statements represent the underlying transactions and events in a manner that achieves fair presentation .

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant
audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding
independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and
where applicable, related safeguards.

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of
the financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditor's report unless law
or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be
communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits
of such communication.

Report on Other Legal and Regulatory Requirements

1. As required by the Companies (Auditor's Report) Order, 2016 ("the Order") issued by the Central Government in terms of Section 143 (11) of
the Act, we give in theAnnexure-Astatement on the matter specified in paragraphs 3 and 4 of the Order.

2. As required by section 143(3) of the Act, we report that:

(a) We have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary for the
purposes of our audit.

(b) In our opinion, proper books of account as required by law have been kept by the Company so far as it appears from our examination of
those books.

(c) The Balance Sheet, the Statement of Profit and Loss and the Cash Flow Statement dealt with by this Report are in agreement with the books
of account.

36
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

(d) In our opinion, the aforesaid financial statements comply with the Accounting Standards specified under Section 133 of the Act, read with
Rule 7 of the Companies (Accounts) Rules, 2014.

(e) On the basis of the written representations received from the directors as on 31 March, 2019 taken on record by the Board of Directors, none
of the directors is disqualified as on 31 March, 2018 from being appointed as a director in terms of Section 164 (2) of the Act.

(f) Since the Company's turnover as per last audited financial statements is less than ` 50 Crores and its borrowings from banks and financial
institutions at any time during the year is less than ` 25 crores, the company is exempted from getting an audit opinion with respect to the
adequacy of the internal financial controls over financial reporting of the company and the operating effectiveness of such control vide
Notification No. G.S.R. 464(E) dated June 13,2017

(g) With respect to the other matters to be included in the Auditor's Report in accordance with Rule 11 of the Companies (Audit and Auditors)
Rule, 2014, in our opinion and to the best of our information and according to the explanations given to us

i) The Company does not have any pending litigation which would impact its financial position;

ii) The Company did not have any long-term contracts including derivative contracts for which there were any material foreseeable losses;

iii) There were no amounts which required to be transferred to the Investor Education and Protection Fund by the Company.

[400500] Disclosures - Secretarial audit report


Unless otherwise specified, all monetary values are in INR
01/04/2018
to
31/03/2019
Disclosure in secretarial audit report explanatory [TextBlock]
Whether secretarial audit report is applicable on company No

37
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[100100] Balance sheet


Unless otherwise specified, all monetary values are in INR
31/03/2019 31/03/2018
Balance sheet [Abstract]
Equity and liabilities [Abstract]
Shareholders' funds [Abstract]
Share capital 16,38,89,270 15,49,14,930
Reserves and surplus 12,99,07,820.56 8,44,43,128.33
Money received against share warrants 0 0
Total shareholders' funds 29,37,97,090.56 23,93,58,058.33
Share application money pending allotment 0 0
Deferred government grants 0 0
Minority interest 0 0
Non-current liabilities [Abstract]
Long-term borrowings 15,69,42,000.52 4,69,05,428
Other long-term liabilities 0 0
Long-term provisions 0 0
Total non-current liabilities 15,69,42,000.52 4,69,05,428
Current liabilities [Abstract]
Short-term borrowings 0 0
Trade payables 0 0
Other current liabilities 0 0
Short-term provisions 3,39,02,528.96 3,11,63,965.4
Total current liabilities 3,39,02,528.96 3,11,63,965.4
Total equity and liabilities 48,46,41,620.04 31,74,27,451.73
Assets [Abstract]
Non-current assets [Abstract]
Fixed assets [Abstract]
Tangible assets 5,54,21,458 3,64,61,325
Intangible assets 1,10,254 2,00,740
Tangible assets capital work-in-progress 35,86,97,517.02 22,76,76,026.8
Intangible assets under development or work-in-progress 0 0
Total fixed assets 41,42,29,229.02 26,43,38,091.8
Non-current investments 3,06,94,888 1,29,50,959
Deferred tax assets (net) 17,71,238 17,43,306
Long-term loans and advances 0 0
Other non-current assets 7,50,000 7,50,000
Total non-current assets 44,74,45,355.02 27,97,82,356.8
Current assets [Abstract]
Current investments 0 0
Inventories 23,31,697 28,13,237
Trade receivables 5,85,924 14,13,180
Cash and bank balances 22,66,429.05 1,20,26,905.06
Short-term loans and advances 2,33,28,446 1,31,11,300.87
Other current assets 86,83,768.97 82,80,472
Total current assets 3,71,96,265.02 3,76,45,094.93
Total assets 48,46,41,620.04 31,74,27,451.73

38
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[400300] Disclosures - Signatories of financial statements

Details of directors signing financial statements [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Directors signing financial statements [Axis] SIGNATORY1 SIGNATORY2
01/04/2018 01/04/2018
to to
31/03/2019 31/03/2019
Details of signatories of financial statements [Abstract]
Details of directors signing financial statements [Abstract]
Details of directors signing financial statements [LineItems]
Name of director signing financial statements [Abstract]
First name of director MANORANJAN BRUNDABAN
Last name of director MOHAPATRA NAHAK
MANAGING
Designation of director DIRECTOR
DIRECTOR

Director identification number of director 07493683 03519673


Date of signing of financial statements by director 07/09/2019 07/09/2019

39
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[100300] Cash flow statement, direct


Unless otherwise specified, all monetary values are in INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Statement of cash flows [Abstract]
Whether cash flow statement is applicable on company Yes Yes
Cash flows from used in operating activities [Abstract]
Classes of cash receipts from operating activities [Abstract]
Receipts from sales of goods and rendering of services 18,43,44,977.07 17,16,77,942.58
Receipts from royalties fees, commissions and other revenue 0 0
Receipts from future contracts, forward contracts, options
contracts and swap contracts held for dealing or trading 0 0
purpose
Receipts from premiums and claims annuities and other policy benefits 0 0
Other cash receipts from operating activities 0 0
Classes of cash payments [Abstract]
Payments to suppliers for goods and services 12,45,61,190.46 11,18,58,023.77
Payments to future contracts, forward contracts, options
contracts and swap contracts held for dealing or trading 0 0
purpose
Payments to and on behalf of employees 3,54,41,978 3,56,87,701
Payments for premiums and claims annuities and other policy benefits 0 0
Other cash payments from operating activities 0 0
Net cash flows from (used in) operations 2,43,41,808.61 2,41,32,217.81
Dividends received 0 0
Interest paid 0 51,331
Interest received 0 0
Income taxes paid (refund) 56,32,799 56,20,264
Other inflows (outflows) of cash 2,75,974.08 35,32,204.97
Net cash flows from (used in) operating activities before extraordinary
1,89,84,983.69 2,19,92,827.78
items
Proceeds from extraordinary items 0 0
Payment for extraordinary items 0 0
Net cash flows from (used in) operating activities 1,89,84,983.69 2,19,92,827.78
Cash flows from used in investing activities [Abstract]
Cash flows from losing control of subsidiaries or other businesses 0 0
Cash flows used in obtaining control of subsidiaries or other businesses 0 0
Other cash receipts from sales of equity or debt instruments of other
78,00,000 1,37,21,776
entities
Other cash payments to acquire equity or debt instruments of other
2,40,00,000 6,00,000
entities
Other cash receipts from sales of interests in joint ventures 0 0
Other cash payments to acquire interests in joint ventures 0 0
Cash receipts from share of profits of partnership firm or
0 0
association of persons or limited liability partnerships
Cash payment for investment in partnership firm or association of
0 0
persons or limited liability partnerships
Proceeds from sales of tangible assets 0 0
Purchase of tangible assets 15,65,26,707.22 12,75,81,907.3
Proceeds from sales of intangible assets 0 0
Purchase of intangible assets 0 0
Cash advances and loans made to other parties 0 0
Cash receipts from repayment of advances and loans made to other parties 0 0
Cash payments for future contracts, forward contracts, option
0 0
contracts and swap contracts
Cash receipts from future contracts, forward contracts, option
0 0
contracts and swap contracts
Dividends received 0 0
Interest received 0 0
Income taxes paid (refund) 0 0
Other inflows (outflows) of cash 0 0

40
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Proceeds from government grants 0 0


Net cash flows from (used in) investing activities before extraordinary
-17,27,26,707.22 -11,44,60,131.3
items
Net cash flows from (used in) investing activities -17,27,26,707.22 -11,44,60,131.3
Cash flows from used in financing activities [Abstract]
Proceeds from issuing shares 89,74,340 1,27,49,930
Proceeds from issuing other equity instruments 2,60,25,586 3,31,49,818
Proceeds from issuing debentures notes bonds etc 0 0
Proceeds from borrowings 10,89,81,321.52 4,65,39,925
Repayments of borrowings 0 0
Dividends paid 0 0
Interest paid 0 0
Income taxes paid (refund) 0 0
Other inflows (outflows) of cash 0 0
Net cash flows from (used in) financing activities before extraordinary
14,39,81,247.52 9,24,39,673
items
Proceeds from extraordinary items 0 0
Payment for extraordinary items 0 0
Net cash flows from (used in) financing activities 14,39,81,247.52 9,24,39,673
Net increase (decrease) in cash and cash equivalents before effect of
-97,60,476.01 -27,630.52
exchange rate changes
Effect of exchange rate changes on cash and cash equivalents [Abstract]
Effect of exchange rate changes on cash and cash equivalents 0 0
Net increase (decrease) in cash and cash equivalents -97,60,476.01 -27,630.52
Cash and cash equivalents cash flow statement at end of period 22,66,429.05 1,20,26,905.06

[200100] Notes - Share capital

Disclosure of shareholding more than five per cent in company [Table] ..(1)
Unless otherwise specified, all monetary values are in INR
Classes of share capital [Axis] Equity shares 1 [Member]
Name of shareholder [Axis] Shareholder 1 [Member] Shareholder 2 [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of shareholding more than five per cent in
company [Abstract]
Disclosure of shareholding more than five per cent
in company [LineItems]
Type of share ORDINARY ORDINARY ORDINARY ORDINARY
KEDAR NATH KEDAR NATH BRUNDABAN BRUNDABAN
Name of shareholder PANDA PANDA NAHAK NAHAK
PAN of shareholder ALUPP7287R ALUPP7287R ACBPN4528K ACBPN4528K
Country of incorporation or residence of
INDIA INDIA INDIA INDIA
shareholder
Number of shares held in company [shares] 37,39,154 [shares] 35,72,488 [shares] 31,25,427 [shares] 29,97,222
Percentage of shareholding in company 23.00% 23.00% 19.00% 19.00%

41
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of shareholding more than five per cent in company [Table] ..(2)
Unless otherwise specified, all monetary values are in INR
Classes of share capital [Axis] Equity shares 1 [Member]
Name of shareholder [Axis] Shareholder 3 [Member] Shareholder 4 [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of shareholding more than five per cent in
company [Abstract]
Disclosure of shareholding more than five per cent
in company [LineItems]
Type of share ORDINARY ORDINARY ORDINARY ORDINARY
SUBODH KUMAR SUBODH KUMAR P R A K A S H PRAKASH
Name of shareholder DAS DAS CHANDRA DALAI CHANDRA DALAI
PAN of shareholder AHSPD2066J AHSPD2066J AIIPD0686R AIIPD0686R
Country of incorporation or residence of
INDIA INDIA INDIA INDIA
shareholder
Number of shares held in company [shares] 33,13,888 [shares] 31,47,222 [shares] 28,34,093 [shares] 27,05,888
Percentage of shareholding in company 20.00% 20.00% 17.00% 17.00%

Disclosure of shareholding more than five per cent in company [Table] ..(3)
Unless otherwise specified, all monetary values are in INR
Classes of share capital [Axis] Equity shares 1 [Member]
Name of shareholder [Axis] Shareholder 5 [Member]
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of shareholding more than five per cent in company [Abstract]
Disclosure of shareholding more than five per cent in company [LineItems]
Type of share ORDINARY ORDINARY
MANORANJAN MANORANJAN
Name of shareholder MOHAPATRA MOHAPATRA
PAN of shareholder ADRPM3649R ADRPM3649R
Country of incorporation or residence of shareholder INDIA INDIA
Number of shares held in company [shares] 10,23,290 [shares] 8,69,444
Percentage of shareholding in company 6.00% 6.00%

42
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of classes of share capital [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Classes of share capital [Axis] Share capital [Member] Equity shares [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of classes of share capital [Abstract]
Disclosure of classes of share capital [LineItems]
Number of shares authorised [shares] 2,50,00,000 [shares] 2,50,00,000 [shares] 2,50,00,000 [shares] 2,50,00,000
Value of shares authorised 25,00,00,000 25,00,00,000 25,00,00,000 25,00,00,000
Number of shares issued [shares] 1,63,88,927 [shares] 1,54,91,493 [shares] 1,63,88,927 [shares] 1,54,91,493
Value of shares issued 16,38,89,270 15,49,14,930 16,38,89,270 15,49,14,930
Number of shares subscribed and fully paid [shares] 1,63,88,927 [shares] 1,54,91,493 [shares] 1,63,88,927 [shares] 1,54,91,493
Value of shares subscribed and fully paid 16,38,89,270 15,49,14,930 16,38,89,270 15,49,14,930
Number of shares subscribed but not fully paid [shares] 0 [shares] 0 [shares] 0 [shares] 0
Value of shares subscribed but not fully paid 0 0 0 0
Total number of shares subscribed [shares] 1,63,88,927 [shares] 1,54,91,493 [shares] 1,63,88,927 [shares] 1,54,91,493
Total value of shares subscribed 16,38,89,270 15,49,14,930 16,38,89,270 15,49,14,930
Value of shares paid-up [Abstract]
Number of shares paid-up [shares] 1,63,88,927 [shares] 1,54,91,493 [shares] 1,63,88,927 [shares] 1,54,91,493
Value of shares called 16,38,89,270 15,49,14,930 16,38,89,270 15,49,14,930
Calls unpaid [Abstract]
Calls unpaid by directors and officers
[Abstract]
Calls unpaid by directors 0 0 0 0
Calls unpaid by officers 0 0 0 0
Total calls unpaid by directors and
0 0 0 0
officers
Calls unpaid by others 0 0 0 0
Total calls unpaid 0 0 0 0
Forfeited shares 0 0 0 0
Forfeited shares reissued 0 0 0 0
Value of shares paid-up 16,38,89,270 15,49,14,930 16,38,89,270 15,49,14,930
Reconciliation of number of shares outstanding
[Abstract]
Changes in number of shares outstanding
[Abstract]
Increase in number of shares outstanding
[Abstract]
Number of shares issued in public offering [shares] 0 [shares] 0 [shares] 0 [shares] 0
Number of shares issued as bonus shares [shares] 0 [shares] 0 [shares] 0 [shares] 0
Number of shares issued as rights [shares] 8,97,434 [shares] 12,74,993 [shares] 8,97,434 [shares] 12,74,993
Number of shares issued in private
placement arising out of conversion of
[shares] 0 [shares] 0 [shares] 0 [shares] 0
debentures preference shares during
period
Number of shares issued in other private
[shares] 0 [shares] 0 [shares] 0 [shares] 0
placement
Number of shares issued as preferential
allotment arising out of conversion of
[shares] 0 [shares] 0 [shares] 0 [shares] 0
debentures preference shares during
period
Number of shares issued as other
[shares] 0 [shares] 0 [shares] 0 [shares] 0
preferential allotment
Number of shares allotted for
contracts without payment received [shares] 0 [shares] 0 [shares] 0 [shares] 0
in cash
Number of shares issued under scheme of
[shares] 0 [shares] 0 [shares] 0 [shares] 0
amalgamation
Number of other issues of shares [shares] 0 [shares] 0 [shares] 0 [shares] 0
Number of shares issued under employee
[shares] 0 [shares] 0 [shares] 0 [shares] 0
stock option plan
Number of other issue of shares
arising out of conversion of [shares] 0 [shares] 0 [shares] 0 [shares] 0
securities
Total aggregate number of shares issued
[shares] 8,97,434 [shares] 12,74,993 [shares] 8,97,434 [shares] 12,74,993
during period

43
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Decrease in number of shares during period


[Abstract]
Number of shares bought back [shares] 0 [shares] 0 [shares] 0 [shares] 0
Other decrease in number of shares [shares] 0 [shares] 0 [shares] 0 [shares] 0
Total decrease in number of shares during
[shares] 0 [shares] 0 [shares] 0 [shares] 0
period
Total increase (decrease) in number of
[shares] 8,97,434 [shares] 12,74,993 [shares] 8,97,434 [shares] 12,74,993
shares outstanding
Number of shares outstanding at end of period [shares] 1,63,88,927 [shares] 1,54,91,493 [shares] 1,63,88,927 [shares] 1,54,91,493
Reconciliation of value of shares outstanding
[Abstract]
Changes in share capital [Abstract]
Increase in share capital during period
[Abstract]
Amount of public issue during period 0 0 0 0
Amount of bonus issue during period 0 0 0 0
Amount of rights issue during period 89,74,340 1,27,49,930 89,74,340 1,27,49,930
Amount of private placement issue
arising out of conversion of debentures 0 0 0 0
preference shares during period
Amount of other private placement issue
0 0 0 0
during period
Amount of preferential allotment issue
arising out of conversion of debentures 0 0 0 0
preference shares during period
Amount of other preferential allotment
0 0 0 0
issue during period
Amount of issue allotted for
contracts without payment 0 0 0 0
received in cash during period
Amount of issue under scheme of
0 0 0 0
amalgamation during period
Amount of other issues during period 0 0 0 0
Amount of employee stock option plan
0 0 0 0
issued during period
Amount of other issue arising out of
conversion of securities during 0 0 0 0
period
Total aggregate amount of increase in
89,74,340 1,27,49,930 89,74,340 1,27,49,930
share capital during period
Decrease in share capital during period
[Abstract]
Decrease in amount of shares bought back 0 0 0 0
Other decrease in amount of shares 0 0 0 0
Total decrease in share capital during
0 0 0 0
period
Total increase (decrease) in share capital 89,74,340 1,27,49,930 89,74,340 1,27,49,930
Share capital at end of period 16,38,89,270 15,49,14,930 16,38,89,270 15,49,14,930
Shares in company held by holding company or
ultimate holding company or by its subsidiaries
or associates [Abstract]
Shares in company held by holding company [shares] 0 [shares] 0 [shares] 0 [shares] 0
Shares in company held by ultimate holding
[shares] 0 [shares] 0 [shares] 0 [shares] 0
company
Shares in company held by subsidiaries of its
[shares] 0 [shares] 0 [shares] 0 [shares] 0
holding company
Shares in company held by subsidiaries of its
[shares] 0 [shares] 0 [shares] 0 [shares] 0
ultimate holding company
Shares in company held by associates of its
[shares] 0 [shares] 0 [shares] 0 [shares] 0
holding company
Shares in company held by associates of its
[shares] 0 [shares] 0 [shares] 0 [shares] 0
ultimate holding company
Total shares in company held by holding company
or ultimate holding company or by its [shares] 0 [shares] 0 [shares] 0 [shares] 0
subsidiaries or associates
Shares reserved for issue under options
and contracts or commitments for sale of [shares] 0 [shares] 0 [shares] 0 [shares] 0
shares or disinvestment

44
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Amount of shares reserved for issue under options


and contracts or commitments for sale of shares or 0 0 0 0
disinvestment
Aggregate number of fully paid-up shares issued
pursuant to contracts without payment being [shares] 0 [shares] 0 [shares] 0 [shares] 0
received in cash during last five years
Aggregate number of fully paid-up shares
issued by way of bonus shares during last [shares] 0 [shares] 0 [shares] 0 [shares] 0
five years
Aggregate number of shares bought back during
[shares] 0 [shares] 0 [shares] 0 [shares] 0
last five years
Original paid-up value of forfeited shares 0 0 0 0
Details of application money received for
allotment of securities and due for refund and
interest accrued thereon [Abstract]
Application money received for allotment of
securities and due for refund and interest
accrued thereon [Abstract]
Application money received for
allotment of securities and due for 0 0 0 0
refund, principal
Application money received for
allotment of securities and due for 0 0 0 0
refund, interest accrued
Total application money received for
allotment of securities and due for refund 0 0 0 0
and interest accrued thereon
Number of shares proposed to be issued [shares] 0 [shares] 0 [shares] 0 [shares] 0
Share premium for shares to be allotted 0 0 0 0

45
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of classes of share capital [Table] ..(2)


Unless otherwise specified, all monetary values are in INR
Classes of share capital [Axis] Equity shares 1 [Member]
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of classes of share capital [Abstract]
Disclosure of classes of share capital [LineItems]
Type of share ORDINARY ORDINARY
Number of shares authorised [shares] 2,50,00,000 [shares] 2,50,00,000
Value of shares authorised 25,00,00,000 25,00,00,000
Number of shares issued [shares] 1,63,88,927 [shares] 1,54,91,493
Value of shares issued 16,38,89,270 15,49,14,930
Number of shares subscribed and fully paid [shares] 1,63,88,927 [shares] 1,54,91,493
Value of shares subscribed and fully paid 16,38,89,270 15,49,14,930
Number of shares subscribed but not fully paid [shares] 0 [shares] 0
Value of shares subscribed but not fully paid 0 0
Total number of shares subscribed [shares] 1,63,88,927 [shares] 1,54,91,493
Total value of shares subscribed 16,38,89,270 15,49,14,930
Value of shares paid-up [Abstract]
Number of shares paid-up [shares] 1,63,88,927 [shares] 1,54,91,493
Value of shares called 16,38,89,270 15,49,14,930
Calls unpaid [Abstract]
Calls unpaid by directors and officers [Abstract]
Calls unpaid by directors 0 0
Calls unpaid by officers 0 0
Total calls unpaid by directors and officers 0 0
Calls unpaid by others 0 0
Total calls unpaid 0 0
Forfeited shares 0 0
Forfeited shares reissued 0 0
Value of shares paid-up 16,38,89,270 15,49,14,930
Par value per share [INR/shares] 10 [INR/shares] 10
Amount per share called in case shares not fully called [INR/shares] 0 [INR/shares] 0
Reconciliation of number of shares outstanding [Abstract]
Changes in number of shares outstanding [Abstract]
Increase in number of shares outstanding [Abstract]
Number of shares issued in public offering [shares] 0 [shares] 0
Number of shares issued as bonus shares [shares] 0 [shares] 0
Number of shares issued as rights [shares] 8,97,434 [shares] 12,74,993
Number of shares issued in private placement arising out of conversion
[shares] 0 [shares] 0
of debentures preference shares during period
Number of shares issued in other private placement [shares] 0 [shares] 0
Number of shares issued as preferential allotment arising out of
[shares] 0 [shares] 0
conversion of debentures preference shares during period
Number of shares issued as other preferential allotment [shares] 0 [shares] 0
Number of shares allotted for contracts without payment received in cash [shares] 0 [shares] 0
Number of shares issued under scheme of amalgamation [shares] 0 [shares] 0
Number of other issues of shares [shares] 0 [shares] 0
Number of shares issued under employee stock option plan [shares] 0 [shares] 0
Number of other issue of shares arising out of conversion of securities [shares] 0 [shares] 0
Total aggregate number of shares issued during period [shares] 8,97,434 [shares] 12,74,993
Decrease in number of shares during period [Abstract]
Number of shares bought back [shares] 0 [shares] 0
Other decrease in number of shares [shares] 0 [shares] 0
Total decrease in number of shares during period [shares] 0 [shares] 0
Total increase (decrease) in number of shares outstanding [shares] 8,97,434 [shares] 12,74,993
Number of shares outstanding at end of period [shares] 1,63,88,927 [shares] 1,54,91,493
Reconciliation of value of shares outstanding [Abstract]
Changes in share capital [Abstract]
Increase in share capital during period [Abstract]
Amount of public issue during period 0 0
Amount of bonus issue during period 0 0
Amount of rights issue during period 89,74,340 1,27,49,930

46
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Amount of private placement issue arising out of conversion of


0 0
debentures preference shares during period
Amount of other private placement issue during period 0 0
Amount of preferential allotment issue arising out of conversion of
0 0
debentures preference shares during period
Amount of other preferential allotment issue during period 0 0
Amount of issue allotted for contracts without payment received in cash
0 0
during period
Amount of issue under scheme of amalgamation during period 0 0
Amount of other issues during period 0 0
Amount of employee stock option plan issued during period 0 0
Amount of other issue arising out of conversion of securities during period 0 0
Total aggregate amount of increase in share capital during period 89,74,340 1,27,49,930
Decrease in share capital during period [Abstract]
Decrease in amount of shares bought back 0 0
Other decrease in amount of shares 0 0
Total decrease in share capital during period 0 0
Total increase (decrease) in share capital 89,74,340 1,27,49,930
Share capital at end of period 16,38,89,270 15,49,14,930
Shares in company held by holding company or ultimate holding company or by its
subsidiaries or associates [Abstract]
Shares in company held by holding company [shares] 0 [shares] 0
Shares in company held by ultimate holding company [shares] 0 [shares] 0
Shares in company held by subsidiaries of its holding company [shares] 0 [shares] 0
Shares in company held by subsidiaries of its ultimate holding company [shares] 0 [shares] 0
Shares in company held by associates of its holding company [shares] 0 [shares] 0
Shares in company held by associates of its ultimate holding company [shares] 0 [shares] 0
Total shares in company held by holding company or ultimate holding company
[shares] 0 [shares] 0
or by its subsidiaries or associates
Shares reserved for issue under options and contracts or commitments for sale of
[shares] 0 [shares] 0
shares or disinvestment
Amount of shares reserved for issue under options and contracts or commitments
0 0
for sale of shares or disinvestment
Aggregate number of fully paid-up shares issued pursuant to contracts
[shares] 0 [shares] 0
without payment being received in cash during last five years
Aggregate number of fully paid-up shares issued by way of bonus shares during last
[shares] 0 [shares] 0
five years
Aggregate number of shares bought back during last five years [shares] 0 [shares] 0
Original paid-up value of forfeited shares 0 0
Details of application money received for allotment of securities and due for
refund and interest accrued thereon [Abstract]
Application money received for allotment of securities and due for refund and
interest accrued thereon [Abstract]
Application money received for allotment of securities and due for refund,
0 0
principal
Application money received for allotment of securities and due for refund,
0 0
interest accrued
Total application money received for allotment of securities and due for
0 0
refund and interest accrued thereon
Number of shares proposed to be issued [shares] 0 [shares] 0
Share premium for shares to be allotted 0 0

Unless otherwise specified, all monetary values are in INR


01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of notes on share capital explanatory [TextBlock]
Whether there are any shareholders holding more than five per cent
Yes Yes
shares in company
Number of persons on private placement of preference share 0 0
Number of shareholders of company 14 14
Number of allottees in case of preferential allotment 0 0
Whether reduction in capital done during year No No
Whether money raised from public offering during year No No

47
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[200200] Notes - Reserves and surplus

Statement of changes in reserves [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Components of reserves [Axis] Reserves [Member] Securities premium account [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Statement of changes in reserves [Abstract]
Statement of changes in reserves [LineItems]
Changes in reserves [Abstract]
Additions to reserves [Abstract]
Profit (loss) for period 1,94,39,106.23 1,41,25,584.81 0 0
Other additions to reserves 2,60,25,586 3,31,49,818 2,60,25,586 3,31,49,818
Total additions to reserves 4,54,64,692.23 4,72,75,402.81 2,60,25,586 3,31,49,818
Deductions to reserves [Abstract]
Securities premium adjusted bonus shares 0 0 0 0
Securities premium adjusted writing off
0 0 0 0
preliminary expenses
Securities premium adjusted writing off
discount expenses issue shares 0 0 0 0
debentures
Securities premium adjusted premium
payable redemption preference shares 0 0 0 0
debentures
Securities premium adjusted purchase
own shares other securities under 0 0 0 0
section 68
Other utilisation of securities premium if
0 0 0 0
permitted
Other deductions to reserves 0 0 0 0
Total deductions to reserves 0 0 0 0
Appropriations for dividend, dividend tax and
general reserve [Abstract]
Dividend appropriation [Abstract]
Interim dividend appropriation [Abstract]
Interim equity dividend appropriation 0 0
Interim preferred dividend
0 0
appropriation
Interim special dividend appropriation 0 0
Total interim dividend appropriation 0 0
Final dividend appropriation [Abstract]
Final equity dividend appropriation 0 0
Final preferred dividend appropriation 0 0
Final special dividend appropriation 0 0
Total final dividend appropriation 0 0
Total dividend appropriation 0 0
Dividend tax appropriation [Abstract]
Equity dividend tax appropriation 0 0
Preferred dividend tax appropriation 0 0
Total dividend tax appropriation 0 0
Other appropriations 0 0 0 0
Transfer to general reserve 0 0 0 0
Total appropriations for dividend,
0 0 0 0
dividend tax and general reserve
Appropriation towards bonus shares 0 0 0 0
Total changes in reserves 4,54,64,692.23 4,72,75,402.81 2,60,25,586 3,31,49,818
Reserves at end of period 12,99,07,820.56 8,44,43,128.33 7,91,76,404 5,31,50,818
Venturer's share of post-acquisition reserves
0 0 0 0
of jointly controlled enterprise

48
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Statement of changes in reserves [Table] ..(2)


Unless otherwise specified, all monetary values are in INR
Components of reserves [Axis] Surplus [Member]
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Statement of changes in reserves [Abstract]
Statement of changes in reserves [LineItems]
Changes in reserves [Abstract]
Additions to reserves [Abstract]
Profit (loss) for period 1,94,39,106.23 1,41,25,584.81
Other additions to reserves 0 0
Total additions to reserves 1,94,39,106.23 1,41,25,584.81
Deductions to reserves [Abstract]
Other utilisation of securities premium if permitted 0 0
Other deductions to reserves 0 0
Total deductions to reserves 0 0
Appropriations for dividend, dividend tax and general reserve [Abstract]
Dividend appropriation [Abstract]
Interim dividend appropriation [Abstract]
Interim equity dividend appropriation 0 0
Interim preferred dividend appropriation 0 0
Interim special dividend appropriation 0 0
Total interim dividend appropriation 0 0
Final dividend appropriation [Abstract]
Final equity dividend appropriation 0 0
Final preferred dividend appropriation 0 0
Final special dividend appropriation 0 0
Total final dividend appropriation 0 0
Total dividend appropriation 0 0
Dividend tax appropriation [Abstract]
Equity dividend tax appropriation 0 0
Preferred dividend tax appropriation 0 0
Total dividend tax appropriation 0 0
Other appropriations 0 0
Transfer to general reserve 0 0
Total appropriations for dividend, dividend tax and general reserve 0 0
Appropriation towards bonus shares 0 0
Total changes in reserves 1,94,39,106.23 1,41,25,584.81
Reserves at end of period 5,07,31,416.56 3,12,92,310.33
Venturer's share of post-acquisition reserves of jointly controlled enterprise 0 0

Unless otherwise specified, all monetary values are in INR


01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of notes on reserves explanatory [TextBlock]
Aggregate amount set aside or proposed to be set aside, to reserve 0 0
Aggregate amounts withdrawn from such reserves set aside 0 0
Share reserves joint ventures 0 0

49
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[200300] Notes - Borrowings

Classification of borrowings [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Classification based on time period [Axis] Long-term [Member]
Classification of borrowings [Axis] Term loans from banks [Member] Rupee term loans from banks [Member]
Subclassification of borrowings [Axis] Secured borrowings [Member] Secured borrowings [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Borrowings notes [Abstract]
Details of borrowings [Abstract]
Details of borrowings [LineItems]
Borrowings 15,69,42,000.52 4,69,05,428 15,69,42,000.52 4,69,05,428
Nature of security [Abstract]
Secured by Secured by
Secured by Secured by
immovable property immovable property
immovable property immovable property
of the company & of the company &
of the company & of the company &
directors, movable directors, movable
Nature of security assets of the
directors, movable
assets of the
directors, movable
assets of the company assets of the company
company & personal company & personal
& personal guarantee & personal guarantee
guarantee of guarantee of
of directors of directors
directors directors
Details on loans guaranteed [Abstract]
Aggregate amount of loans guaranteed by
0 0 0 0
directors
Aggregate amount of loans guaranteed by
0 0 0 0
others
terms are as per loan terms are as per loan terms are as per loan terms are as per loan
Terms of repayment of term loans and other loans agreement with the agreement with the agreement with the agreement with the
banks banks banks banks
Details on defaults on borrowings [Abstract]
Outstanding amount of continuing default
0 0 0 0
principal
Outstanding amount of continuing default
0 0 0 0
interest

50
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[201000] Notes - Tangible assets

Disclosure of tangible assets [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Classes of tangible assets [Axis] Company total tangible assets [Member]
Sub classes of tangible assets [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross Gross carrying amount Accumulated depreciation and
Carrying amount [Member]
carrying amount [Axis] [Member] impairment [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of tangible assets [Abstract]
Disclosure of tangible assets
[LineItems]
Reconciliation of changes in
tangible assets [Abstract]
Changes in tangible assets
[Abstract]
Additions other than through
business combinations tangible 2,56,35,423 14,94,432 2,56,35,423 14,94,432
assets
Acquisitions through
business combinations 0 0 0 0
tangible assets
Depreciation tangible assets -66,75,290 -1,01,85,962 66,75,290 1,01,85,962
Impairment loss
recognised in profit or 0 0 0 0
loss tangible assets
Reversal of impairment loss
recognised in profit or loss 0 0 0 0
tangible assets
Revaluation increase
0 0 0 0
(decrease) tangible assets
Disposals tangible assets
[Abstract]
Disposals tangible assets
0 0 0 0 0 0
through demergers
Disposals tangible assets,
0 0 0 0 0 0
others
Total disposals tangible
0 0 0 0 0 0
assets
Other adjustments tangible
assets [Abstract]
Increase (decrease) through
net exchange differences 0 0 0 0
tangible assets
Other adjustments tangible
0 0 0 0 0 0
assets, others
Total other adjustments
0 0 0 0 0 0
tangible assets
Total changes in tangible
1,89,60,133 -86,91,530 2,56,35,423 14,94,432 66,75,290 1,01,85,962
assets
Tangible assets at end of period 5,54,21,458 3,64,61,325 13,06,60,423 10,50,25,000 7,52,38,965 6,85,63,675

51
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of tangible assets [Table] ..(2)


Unless otherwise specified, all monetary values are in INR
Classes of tangible assets [Axis] Land [Member]
Sub classes of tangible assets [Axis] Owned and leased assets [Member] Owned assets [Member]
Accumulated
Accumulated
Carrying Gross carrying Carrying Gross carrying depreciation
Carrying amount accumulated depreciation and gross depreciation
amount amount amount amount and
carrying amount [Axis] and impairment
[Member] [Member] [Member] [Member] impairment
[Member]
[Member]
01/04/2018 01/04/2018 01/04/2018 01/04/2018 01/04/2018 01/04/2018
to to to to to to
31/03/2019 31/03/2019 31/03/2019 31/03/2019 31/03/2019 31/03/2019
Disclosure of tangible assets [Abstract]
Disclosure of tangible assets
[LineItems]
Reconciliation of changes in
tangible assets [Abstract]
Changes in tangible assets
[Abstract]
Additions other than through
business combinations tangible 2,53,37,375 2,53,37,375 2,53,37,375 2,53,37,375
assets
Acquisitions through
business combinations 0 0 0 0
tangible assets
Depreciation tangible assets 0 0 0 0
Impairment loss
recognised in profit or 0 0 0 0
loss tangible assets
Reversal of impairment loss
recognised in profit or loss 0 0 0 0
tangible assets
Revaluation increase
0 0 0 0
(decrease) tangible assets
Disposals tangible assets
[Abstract]
Disposals tangible assets
0 0 0 0 0 0
through demergers
Disposals tangible assets,
0 0 0 0 0 0
others
Total disposals tangible
0 0 0 0 0 0
assets
Other adjustments tangible
assets [Abstract]
Increase (decrease) through
net exchange differences 0 0 0 0
tangible assets
Other adjustments tangible
0 0 0 0 0 0
assets, others
Total other adjustments
0 0 0 0 0 0
tangible assets
Total changes in tangible
2,53,37,375 2,53,37,375 0 2,53,37,375 2,53,37,375 0
assets
Tangible assets at end of period 4,30,50,108 4,30,50,108 0 4,30,50,108 4,30,50,108 0

52
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of tangible assets [Table] ..(3)


Unless otherwise specified, all monetary values are in INR
Classes of tangible assets [Axis] Plant and equipment [Member] Factory equipments [Member]
Sub classes of tangible assets [Axis] Owned and leased assets [Member] Owned and leased assets [Member]
Accumulated
Accumulated
Carrying Gross carrying Carrying Gross carrying depreciation
Carrying amount accumulated depreciation and gross depreciation
amount amount amount amount and
carrying amount [Axis] and impairment
[Member] [Member] [Member] [Member] impairment
[Member]
[Member]
01/04/2018 01/04/2018 01/04/2018 01/04/2018 01/04/2018 01/04/2018
to to to to to to
31/03/2019 31/03/2019 31/03/2019 31/03/2019 31/03/2019 31/03/2019
Disclosure of tangible assets [Abstract]
Disclosure of tangible assets
[LineItems]
Reconciliation of changes in
tangible assets [Abstract]
Changes in tangible assets
[Abstract]
Additions other than through
business combinations tangible 1,08,510 1,08,510 65,510 65,510
assets
Acquisitions through
business combinations 0 0 0 0
tangible assets
Depreciation tangible assets -54,58,708 54,58,708 -45,00,263 45,00,263
Impairment loss
recognised in profit or 0 0 0 0
loss tangible assets
Reversal of impairment loss
recognised in profit or loss 0 0 0 0
tangible assets
Revaluation increase
0 0 0 0
(decrease) tangible assets
Disposals tangible assets
[Abstract]
Disposals tangible assets
0 0 0 0 0 0
through demergers
Disposals tangible assets,
0 0 0 0 0 0
others
Total disposals tangible
0 0 0 0 0 0
assets
Other adjustments tangible
assets [Abstract]
Increase (decrease) through
net exchange differences 0 0 0 0
tangible assets
Other adjustments tangible
0 0 0 0 0 0
assets, others
Total other adjustments
0 0 0 0 0 0
tangible assets
Total changes in tangible
-53,50,198 1,08,510 54,58,708 -44,34,753 65,510 45,00,263
assets
Tangible assets at end of period 97,13,534 7,29,72,500 6,32,58,966 70,65,067 6,26,49,105 5,55,84,038

53
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of tangible assets [Table] ..(4)


Unless otherwise specified, all monetary values are in INR
Classes of tangible assets [Axis] Factory equipments [Member] Other plant and equipment [Member]
Sub classes of tangible assets [Axis] Owned assets [Member] Owned and leased assets [Member]
Accumulated
Accumulated
Carrying Gross carrying Carrying Gross carrying depreciation
Carrying amount accumulated depreciation and gross depreciation
amount amount amount amount and
carrying amount [Axis] and impairment
[Member] [Member] [Member] [Member] impairment
[Member]
[Member]
01/04/2018 01/04/2018 01/04/2018 01/04/2018 01/04/2018 01/04/2018
to to to to to to
31/03/2019 31/03/2019 31/03/2019 31/03/2019 31/03/2019 31/03/2019
Disclosure of tangible assets [Abstract]
Disclosure of tangible assets
[LineItems]
Reconciliation of changes in
tangible assets [Abstract]
Changes in tangible assets
[Abstract]
Additions other than through
business combinations tangible 65,510 65,510 43,000 43,000
assets
Acquisitions through
business combinations 0 0 0 0
tangible assets
Depreciation tangible assets -45,00,263 45,00,263 -9,58,445 9,58,445
Impairment loss
recognised in profit or 0 0 0 0
loss tangible assets
Reversal of impairment loss
recognised in profit or loss 0 0 0 0
tangible assets
Revaluation increase
0 0 0 0
(decrease) tangible assets
Disposals tangible assets
[Abstract]
Disposals tangible assets
0 0 0 0 0 0
through demergers
Disposals tangible assets,
0 0 0 0 0 0
others
Total disposals tangible
0 0 0 0 0 0
assets
Other adjustments tangible
assets [Abstract]
Increase (decrease) through
net exchange differences 0 0 0 0
tangible assets
Other adjustments tangible
0 0 0 0 0 0
assets, others
Total other adjustments
0 0 0 0 0 0
tangible assets
Total changes in tangible
-44,34,753 65,510 45,00,263 -9,15,445 43,000 9,58,445
assets
Tangible assets at end of period 70,65,067 6,26,49,105 5,55,84,038 26,48,467 1,03,23,395 76,74,928

54
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of tangible assets [Table] ..(5)


Unless otherwise specified, all monetary values are in INR
Classes of tangible assets [Axis] Other plant and equipment [Member] Furniture and fixtures [Member]
Sub classes of tangible assets [Axis] Owned assets [Member] Owned and leased assets [Member]
Accumulated
Accumulated
Carrying Gross carrying Carrying Gross carrying depreciation
Carrying amount accumulated depreciation and gross depreciation
amount amount amount amount and
carrying amount [Axis] and impairment
[Member] [Member] [Member] [Member] impairment
[Member]
[Member]
01/04/2018 01/04/2018 01/04/2018 01/04/2018 01/04/2018 01/04/2018
to to to to to to
31/03/2019 31/03/2019 31/03/2019 31/03/2019 31/03/2019 31/03/2019
Disclosure of tangible assets [Abstract]
Disclosure of tangible assets
[LineItems]
Reconciliation of changes in
tangible assets [Abstract]
Changes in tangible assets
[Abstract]
Additions other than through
business combinations tangible 43,000 43,000 57,188 57,188
assets
Acquisitions through
business combinations 0 0 0 0
tangible assets
Depreciation tangible assets -9,58,445 9,58,445 -9,11,700 9,11,700
Impairment loss
recognised in profit or 0 0 0 0
loss tangible assets
Reversal of impairment loss
recognised in profit or loss 0 0 0 0
tangible assets
Revaluation increase
0 0 0 0
(decrease) tangible assets
Disposals tangible assets
[Abstract]
Disposals tangible assets
0 0 0 0 0 0
through demergers
Disposals tangible assets,
0 0 0 0 0 0
others
Total disposals tangible
0 0 0 0 0 0
assets
Other adjustments tangible
assets [Abstract]
Increase (decrease) through
net exchange differences 0 0 0 0
tangible assets
Other adjustments tangible
0 0 0 0 0 0
assets, others
Total other adjustments
0 0 0 0 0 0
tangible assets
Total changes in tangible
-9,15,445 43,000 9,58,445 -8,54,512 57,188 9,11,700
assets
Tangible assets at end of period 26,48,467 1,03,23,395 76,74,928 20,43,048 1,11,25,102 90,82,054

55
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of tangible assets [Table] ..(6)


Unless otherwise specified, all monetary values are in INR
Classes of tangible assets [Axis] Furniture and fixtures [Member] Vehicles [Member]
Sub classes of tangible assets [Axis] Owned assets [Member] Owned and leased assets [Member]
Accumulated
Accumulated
Carrying Gross carrying Carrying Gross carrying depreciation
Carrying amount accumulated depreciation and gross depreciation
amount amount amount amount and
carrying amount [Axis] and impairment
[Member] [Member] [Member] [Member] impairment
[Member]
[Member]
01/04/2018 01/04/2018 01/04/2018 01/04/2018 01/04/2018 01/04/2018
to to to to to to
31/03/2019 31/03/2019 31/03/2019 31/03/2019 31/03/2019 31/03/2019
Disclosure of tangible assets [Abstract]
Disclosure of tangible assets
[LineItems]
Reconciliation of changes in
tangible assets [Abstract]
Changes in tangible assets
[Abstract]
Additions other than through
business combinations tangible 57,188 57,188 0 0
assets
Acquisitions through
business combinations 0 0 0 0
tangible assets
Depreciation tangible assets -9,11,700 9,11,700 -1,26,025 1,26,025
Impairment loss
recognised in profit or 0 0 0 0
loss tangible assets
Reversal of impairment loss
recognised in profit or loss 0 0 0 0
tangible assets
Revaluation increase
0 0 0 0
(decrease) tangible assets
Disposals tangible assets
[Abstract]
Disposals tangible assets
0 0 0 0 0 0
through demergers
Disposals tangible assets,
0 0 0 0 0 0
others
Total disposals tangible
0 0 0 0 0 0
assets
Other adjustments tangible
assets [Abstract]
Increase (decrease) through
net exchange differences 0 0 0 0
tangible assets
Other adjustments tangible
0 0 0 0 0 0
assets, others
Total other adjustments
0 0 0 0 0 0
tangible assets
Total changes in tangible
-8,54,512 57,188 9,11,700 -1,26,025 0 1,26,025
assets
Tangible assets at end of period 20,43,048 1,11,25,102 90,82,054 3,60,740 7,63,891 4,03,151

56
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of tangible assets [Table] ..(7)


Unless otherwise specified, all monetary values are in INR
Classes of tangible assets [Axis] Motor vehicles [Member]
Sub classes of tangible assets [Axis] Owned and leased assets [Member] Owned assets [Member]
Accumulated
Accumulated
Carrying Gross carrying Carrying Gross carrying depreciation
Carrying amount accumulated depreciation and gross depreciation
amount amount amount amount and
carrying amount [Axis] and impairment
[Member] [Member] [Member] [Member] impairment
[Member]
[Member]
01/04/2018 01/04/2018 01/04/2018 01/04/2018 01/04/2018 01/04/2018
to to to to to to
31/03/2019 31/03/2019 31/03/2019 31/03/2019 31/03/2019 31/03/2019
Disclosure of tangible assets [Abstract]
Disclosure of tangible assets
[LineItems]
Reconciliation of changes in
tangible assets [Abstract]
Changes in tangible assets
[Abstract]
Additions other than through
business combinations tangible 0 0 0 0
assets
Acquisitions through
business combinations 0 0 0 0
tangible assets
Depreciation tangible assets -1,26,025 1,26,025 -1,26,025 1,26,025
Impairment loss
recognised in profit or 0 0 0 0
loss tangible assets
Reversal of impairment loss
recognised in profit or loss 0 0 0 0
tangible assets
Revaluation increase
0 0 0 0
(decrease) tangible assets
Disposals tangible assets
[Abstract]
Disposals tangible assets
0 0 0 0 0 0
through demergers
Disposals tangible assets,
0 0 0 0 0 0
others
Total disposals tangible
0 0 0 0 0 0
assets
Other adjustments tangible
assets [Abstract]
Increase (decrease) through
net exchange differences 0 0 0 0
tangible assets
Other adjustments tangible
0 0 0 0 0 0
assets, others
Total other adjustments
0 0 0 0 0 0
tangible assets
Total changes in tangible
-1,26,025 0 1,26,025 -1,26,025 0 1,26,025
assets
Tangible assets at end of period 3,60,740 7,63,891 4,03,151 3,60,740 7,63,891 4,03,151

57
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of tangible assets [Table] ..(8)


Unless otherwise specified, all monetary values are in INR
Classes of tangible assets [Axis] Computer equipments [Member]
Sub classes of tangible assets [Axis] Owned and leased assets [Member] Owned assets [Member]
Accumulated
Accumulated
Carrying Gross carrying Carrying Gross carrying depreciation
Carrying amount accumulated depreciation and gross depreciation
amount amount amount amount and
carrying amount [Axis] and impairment
[Member] [Member] [Member] [Member] impairment
[Member]
[Member]
01/04/2018 01/04/2018 01/04/2018 01/04/2018 01/04/2018 01/04/2018
to to to to to to
31/03/2019 31/03/2019 31/03/2019 31/03/2019 31/03/2019 31/03/2019
Disclosure of tangible assets [Abstract]
Disclosure of tangible assets
[LineItems]
Reconciliation of changes in
tangible assets [Abstract]
Changes in tangible assets
[Abstract]
Additions other than through
business combinations tangible 1,32,350 1,32,350 1,32,350 1,32,350
assets
Acquisitions through
business combinations 0 0 0 0
tangible assets
Depreciation tangible assets -1,78,857 1,78,857 -1,78,857 1,78,857
Impairment loss
recognised in profit or 0 0 0 0
loss tangible assets
Reversal of impairment loss
recognised in profit or loss 0 0 0 0
tangible assets
Revaluation increase
0 0 0 0
(decrease) tangible assets
Disposals tangible assets
[Abstract]
Disposals tangible assets
0 0 0 0 0 0
through demergers
Disposals tangible assets,
0 0 0 0 0 0
others
Total disposals tangible
0 0 0 0 0 0
assets
Other adjustments tangible
assets [Abstract]
Increase (decrease) through
net exchange differences 0 0 0 0
tangible assets
Other adjustments tangible
0 0 0 0 0 0
assets, others
Total other adjustments
0 0 0 0 0 0
tangible assets
Total changes in tangible
-46,507 1,32,350 1,78,857 -46,507 1,32,350 1,78,857
assets
Tangible assets at end of period 2,54,028 27,48,822 24,94,794 2,54,028 27,48,822 24,94,794

58
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of tangible assets [Table] ..(9)


Unless otherwise specified, all monetary values are in INR
Classes of tangible assets [Axis] Other tangible assets [Member] Other tangible assets, others [Member]
Sub classes of tangible assets [Axis] Owned and leased assets [Member] Owned and leased assets [Member]
Accumulated
Accumulated
Carrying Gross carrying Carrying Gross carrying depreciation
Carrying amount accumulated depreciation and gross depreciation
amount amount amount amount and
carrying amount [Axis] and impairment
[Member] [Member] [Member] [Member] impairment
[Member]
[Member]
01/04/2017 01/04/2017 01/04/2017 01/04/2017 01/04/2017 01/04/2017
to to to to to to
31/03/2018 31/03/2018 31/03/2018 31/03/2018 31/03/2018 31/03/2018
Disclosure of tangible assets [Abstract]
Disclosure of tangible assets
[LineItems]
Nature of other tangible assets ALL ASSETS ALL ASSETS ALL ASSETS
Reconciliation of changes in
tangible assets [Abstract]
Changes in tangible assets
[Abstract]
Additions other than through
business combinations tangible 14,94,432 14,94,432 14,94,432 14,94,432
assets
Acquisitions through
business combinations 0 0 0 0
tangible assets
Depreciation tangible assets -1,01,85,962 1,01,85,962 -1,01,85,962 1,01,85,962
Impairment loss
recognised in profit or 0 0 0 0
loss tangible assets
Reversal of impairment loss
recognised in profit or loss 0 0 0 0
tangible assets
Revaluation increase
0 0 0 0
(decrease) tangible assets
Disposals tangible assets
[Abstract]
Disposals tangible assets
0 0 0 0 0 0
through demergers
Disposals tangible assets,
0 0 0 0 0 0
others
Total disposals tangible
0 0 0 0 0 0
assets
Other adjustments tangible
assets [Abstract]
Increase (decrease) through
net exchange differences 0 0 0 0
tangible assets
Other adjustments tangible
0 0 0 0 0 0
assets, others
Total other adjustments
0 0 0 0 0 0
tangible assets
Total changes in tangible
-86,91,530 14,94,432 1,01,85,962 -86,91,530 14,94,432 1,01,85,962
assets
Tangible assets at end of period 3,64,61,325 10,50,25,000 6,85,63,675 3,64,61,325 10,50,25,000 6,85,63,675

59
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of tangible assets [Table] ..(10)


Unless otherwise specified, all monetary values are in INR
Classes of tangible assets [Axis] Other tangible assets, others [Member]
Sub classes of tangible assets [Axis] Owned assets [Member]
Accumulated
Carrying amount Gross carrying depreciation and
Carrying amount accumulated depreciation and gross carrying amount [Axis]
[Member] amount [Member] impairment
[Member]
01/04/2017 01/04/2017 01/04/2017
to to to
31/03/2018 31/03/2018 31/03/2018
Disclosure of tangible assets [Abstract]
Disclosure of tangible assets [LineItems]
Nature of other tangible assets ALL ASSETS ALL ASSETS ALL ASSETS
Reconciliation of changes in tangible assets [Abstract]
Changes in tangible assets [Abstract]
Additions other than through business combinations tangible
14,94,432 14,94,432
assets
Acquisitions through business combinations tangible assets 0 0
Depreciation tangible assets -1,01,85,962 1,01,85,962
Impairment loss recognised in profit or loss tangible assets 0 0
Reversal of impairment loss recognised in profit or loss
0 0
tangible assets
Revaluation increase (decrease) tangible assets 0 0
Disposals tangible assets [Abstract]
Disposals tangible assets through demergers 0 0 0
Disposals tangible assets, others 0 0 0
Total disposals tangible assets 0 0 0
Other adjustments tangible assets [Abstract]
Increase (decrease) through net exchange differences
0 0
tangible assets
Other adjustments tangible assets, others 0 0 0
Total other adjustments tangible assets 0 0 0
Total changes in tangible assets -86,91,530 14,94,432 1,01,85,962
Tangible assets at end of period 3,64,61,325 10,50,25,000 6,85,63,675

Disclosure of additional information tangible assets [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Plant and Factory
Company total tangible assets
Classes of tangible assets [Axis] Land [Member] equipment equipments
[Member]
[Member] [Member]
Owned and Owned and Owned and
Owned and leased assets Owned assets
Sub classes of tangible assets [Axis] leased assets leased assets leased assets
[Member] [Member]
[Member] [Member] [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2018 01/04/2018 01/04/2018
to to to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2019 31/03/2019 31/03/2019
Disclosure of additional information
tangible assets [Abstract]
Disclosure of additional information
tangible assets [LineItems]
Depreciation method tangible assets WDV method WDV method WDV method WDV method WDV method WDV method
as per Schedule as per Schedule as per Schedule as per Schedule as per Schedule as per Schedule
Useful lives or depreciation rates II of the II of the II of the II of the II of the II of the
tangible assets Companies Act, Companies Act, Companies Act, Companies Act, Companies Act, Companies
2013 2013 2013 2013 2013 Act, 2013

60
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of additional information tangible assets [Table] ..(2)


Unless otherwise specified, all monetary values are in INR
Factory
Other plant and equipment Vehicles
Classes of tangible assets [Axis] equipments Furniture and fixtures [Member]
[Member] [Member]
[Member]
Owned and Owned and Owned and
Owned assets Owned assets Owned assets
Sub classes of tangible assets [Axis] leased assets leased assets leased assets
[Member] [Member] [Member]
[Member] [Member] [Member]
01/04/2018 01/04/2018 01/04/2018 01/04/2018 01/04/2018 01/04/2018
to to to to to to
31/03/2019 31/03/2019 31/03/2019 31/03/2019 31/03/2019 31/03/2019
Disclosure of additional information
tangible assets [Abstract]
Disclosure of additional information
tangible assets [LineItems]
Depreciation method tangible assets WDV method WDV method WDV method WDV method WDV method WDV method
as per Schedule as per Schedule as per Schedule as per Schedule as per Schedule as per Schedule
Useful lives or depreciation rates II of the II of the II of the II of the II of the II of the
tangible assets Companies Act, Companies Act, Companies Act, Companies Act, Companies Act, Companies
2013 2013 2013 2013 2013 Act, 2013

Disclosure of additional information tangible assets [Table] ..(3)


Unless otherwise specified, all monetary values are in INR
Other tangible
Other tangible
Classes of tangible assets [Axis] Motor vehicles [Member] Computer equipments [Member] assets, others
assets [Member]
[Member]
Owned and Owned and Owned and Owned and
Owned assets Owned assets
Sub classes of tangible assets [Axis] leased assets leased assets leased assets leased assets
[Member] [Member]
[Member] [Member] [Member] [Member]
01/04/2018 01/04/2018 01/04/2018 01/04/2018 01/04/2017 01/04/2017
to to to to to to
31/03/2019 31/03/2019 31/03/2019 31/03/2019 31/03/2018 31/03/2018
Disclosure of additional information
tangible assets [Abstract]
Disclosure of additional information
tangible assets [LineItems]
Depreciation method tangible assets WDV method WDV method WDV method WDV method WDV method WDV method
as per Schedule as per Schedule as per Schedule as per Schedule as per Schedule as per Schedule
Useful lives or depreciation rates II of the II of the II of the II of the II of the II of the
tangible assets Companies Act, Companies Act, Companies Act, Companies Act, Companies Act, Companies
2013 2013 2013 2013 2013 Act, 2013

Disclosure of additional information tangible assets [Table] ..(4)


Unless otherwise specified, all monetary values are in INR
Other tangible
Classes of tangible assets [Axis] assets, others
[Member]
Owned assets
Sub classes of tangible assets [Axis]
[Member]
01/04/2017
to
31/03/2018
Disclosure of additional information tangible assets [Abstract]
Disclosure of additional information tangible assets [LineItems]
Depreciation method tangible assets WDV method
as per Schedule II of
Useful lives or depreciation rates tangible assets the Companies Act,
2013

61
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[201100] Notes - Intangible assets

Disclosure of intangible assets [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Classes of intangible assets [Axis] Company total intangible assets [Member]
Sub classes of intangible assets [Axis] Internally generated and other than internally generated intangible assets [Member]
Carrying amount accumulated amortization and Gross carrying amount Accumulated amortization and
Carrying amount [Member]
impairment and gross carrying amount [Axis] [Member] impairment [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of intangible assets [Abstract]
Disclosure of intangible assets
[LineItems]
Reconciliation of changes in
intangible assets [Abstract]
Changes in intangible assets
[Abstract]
Additions to intangible assets
[Abstract]
Additions through internal
0 0 0 0
development
Additions other than through
business combinations 0 0 0 0
intangible assets
Acquisitions through
business combinations 0 0 0 0
intangible assets
Total additions to
0 0 0 0
intangible assets
Amortization intangible assets -90,486 -1,64,724 90,486 1,64,724
Impairment loss
recognised in profit or 0 0 0 0
loss intangible assets
Reversal of impairment loss
recognised in profit or loss 0 0 0 0
intangible assets
Revaluation increase
0 0 0 0
(decrease) intangible assets
Disposals intangible assets
[Abstract]
Disposals intangible
0 0 0 0 0 0
assets through demergers
Disposals intangible
0 0 0 0 0 0
assets, others
Total disposals intangible
0 0 0 0 0 0
assets
Retirements of intangible
0 0 0 0 0 0
assets
Other adjustments intangible
assets [Abstract]
Increase (decrease) through
net exchange differences 0 0 0 0
intangible assets
Other adjustments
0 0 0 0 0 0
intangible assets, others
Total other adjustments
0 0 0 0 0 0
intangible assets
Total changes in intangible
-90,486 -1,64,724 0 0 90,486 1,64,724
assets
Intangible assets at end of period 1,10,254 2,00,740 11,37,630 11,37,630 10,27,376 9,36,890

62
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of intangible assets [Table] ..(2)


Unless otherwise specified, all monetary values are in INR
Classes of intangible assets [Axis] Computer software [Member]
Sub classes of intangible assets [Axis] Internally generated and other than internally generated intangible assets [Member]
Carrying amount accumulated amortization and Gross carrying amount Accumulated amortization and
Carrying amount [Member]
impairment and gross carrying amount [Axis] [Member] impairment [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of intangible assets [Abstract]
Disclosure of intangible assets
[LineItems]
Reconciliation of changes in
intangible assets [Abstract]
Changes in intangible assets
[Abstract]
Additions to intangible assets
[Abstract]
Additions through internal
0 0 0 0
development
Additions other than through
business combinations 0 0 0 0
intangible assets
Acquisitions through
business combinations 0 0 0 0
intangible assets
Total additions to
0 0 0 0
intangible assets
Amortization intangible assets -90,486 -1,64,724 90,486 1,64,724
Impairment loss
recognised in profit or 0 0 0 0
loss intangible assets
Reversal of impairment loss
recognised in profit or loss 0 0 0 0
intangible assets
Revaluation increase
0 0 0 0
(decrease) intangible assets
Disposals intangible assets
[Abstract]
Disposals intangible
0 0 0 0 0 0
assets through demergers
Disposals intangible
0 0 0 0 0 0
assets, others
Total disposals intangible
0 0 0 0 0 0
assets
Retirements of intangible
0 0 0 0 0 0
assets
Other adjustments intangible
assets [Abstract]
Increase (decrease) through
net exchange differences 0 0 0 0
intangible assets
Other adjustments
0 0 0 0 0 0
intangible assets, others
Total other adjustments
0 0 0 0 0 0
intangible assets
Total changes in intangible
-90,486 -1,64,724 0 0 90,486 1,64,724
assets
Intangible assets at end of period 1,10,254 2,00,740 11,37,630 11,37,630 10,27,376 9,36,890

63
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of intangible assets [Table] ..(3)


Unless otherwise specified, all monetary values are in INR
Classes of intangible assets [Axis] Computer software [Member]
Sub classes of intangible assets [Axis] Intangible assets other than internally generated [Member]
Carrying amount accumulated amortization and Gross carrying amount Accumulated amortization and
Carrying amount [Member]
impairment and gross carrying amount [Axis] [Member] impairment [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of intangible assets [Abstract]
Disclosure of intangible assets
[LineItems]
Reconciliation of changes in
intangible assets [Abstract]
Changes in intangible assets
[Abstract]
Additions to intangible assets
[Abstract]
Additions through internal
0 0 0 0
development
Additions other than through
business combinations 0 0 0 0
intangible assets
Acquisitions through
business combinations 0 0 0 0
intangible assets
Total additions to
0 0 0 0
intangible assets
Amortization intangible assets -90,486 -1,64,724 90,486 1,64,724
Impairment loss
recognised in profit or 0 0 0 0
loss intangible assets
Reversal of impairment loss
recognised in profit or loss 0 0 0 0
intangible assets
Revaluation increase
0 0 0 0
(decrease) intangible assets
Disposals intangible assets
[Abstract]
Disposals intangible
0 0 0 0 0 0
assets through demergers
Disposals intangible
0 0 0 0 0 0
assets, others
Total disposals intangible
0 0 0 0 0 0
assets
Retirements of intangible
0 0 0 0 0 0
assets
Other adjustments intangible
assets [Abstract]
Increase (decrease) through
net exchange differences 0 0 0 0
intangible assets
Other adjustments
0 0 0 0 0 0
intangible assets, others
Total other adjustments
0 0 0 0 0 0
intangible assets
Total changes in intangible
-90,486 -1,64,724 0 0 90,486 1,64,724
assets
Intangible assets at end of period 1,10,254 2,00,740 11,37,630 11,37,630 10,27,376 9,36,890

64
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of additional information intangible assets [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Company total intangible assets
Classes of intangible assets [Axis] Computer software [Member]
[Member]
Internally generated and other Internally generated and other
Intangible assets other than
Sub classes of intangible assets [Axis] than internally generated than internally generated
internally generated [Member]
intangible assets [Member] intangible assets [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of additional information
intangible assets [Abstract]
Disclosure of additional information
intangible assets [LineItems]
Useful lives or amortization rates
WDV WDV WDV WDV WDV WDV
intangible assets
as per Schedule as per Schedule as per Schedule as per Schedule as per Schedule as per Schedule
Description of amortization method II of the II of the II of the II of the II of the II of the
used Companies Act, Companies Act, Companies Act, Companies Act, Companies Act, Companies
2013 2013 2013 2013 2013 Act, 2013

[200400] Notes - Non-current investments

Details of non-current investments [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Classification of non-current investments [Axis] INVESTMENT
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Non-current investments [Abstract]
Disclosure of details of non-current investments [Abstract]
Details of non-current investments [LineItems]
Other non-current Other non-current
Type of non-current investments investments investments
Class of non-current investments Other investments Other investments
Nature of non-current investments FIXED DEPOSIT FIXED DEPOSIT
Non-current investments 3,06,94,888 1,29,50,959
Name of body corporate in whom investment has been made NA NA

Unless otherwise specified, all monetary values are in INR


31/03/2019 31/03/2018
Disclosure of notes on non-current investments explanatory [TextBlock]
Aggregate amount of quoted non-current investments 0 0
Market value of quoted non-current investments 0 0
Aggregate amount of unquoted non-current investments 3,06,94,888 1,29,50,959
Aggregate provision for diminution in value of non-current investments 0 0
Share non-current investments joint ventures 0 0

65
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[200600] Notes - Subclassification and notes on liabilities and assets

Disclosure of breakup of provisions [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Classification based on time period [Axis] Short-term [Member]
31/03/2019 31/03/2018
Subclassification and notes on liabilities and assets [Abstract]
Provisions notes [Abstract]
Disclosure of breakup of provisions [Abstract]
Disclosure of breakup of provisions [LineItems]
Provisions [Abstract]
Provisions for employee benefits [Abstract]
Provision gratuity 0 0
Provision leave encashment 0 0
Provision pension 0 0
Provision employee insurance scheme 95,020 75,170
Provision other employee related liabilities 28,11,952 26,61,169
Total provisions for employee benefits 29,06,972 27,36,339
Provision for corporate tax [Abstract]
Provision for current tax 75,79,945 56,32,799
Provision for wealth tax 0 0
Provision for fringe benefit tax 0 0
Provision for other tax 3,26,660 5,55,011.84
Provision for corporate dividend tax 0 0
Total provision for corporate tax 79,06,605 61,87,810.84
Provision for proposed dividend [Abstract]
Provision for proposed equity dividend [Abstract]
Provision for proposed equity interim dividend 0 0
Provision for proposed equity final dividend 0 0
Provision for proposed equity special dividend 0 0
Total provision for proposed equity dividend 0 0
Provision for proposed preference dividend [Abstract]
Provision for proposed preference interim dividend 0 0
Provision for proposed preference final dividend 0 0
Provision for proposed preference special dividend 0 0
Total provision for proposed preference dividend 0 0
Total provision for proposed dividend 0 0
Provision for statutory liabilities 0 0
CSR expenditure provision 0 0
Provision for abandonment cost 0 0
Other provisions 2,30,88,951.96 2,22,39,815.56
Total provisions 3,39,02,528.96 3,11,63,965.4

66
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Loans and advances [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Classification based on time period [Axis] Short-term [Member]
Other loans and advances, others
Classification of loans and advances [Axis]
[Member]
Classification of assets based on security [Axis] Unsecured considered good [Member]
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Subclassification and notes on liabilities and assets [Abstract]
Loans and advances notes [Abstract]
Loans and advances [Abstract]
Disclosure of loans and advances [LineItems]
Loans and advances, gross 2,33,28,446 1,31,11,300.87
Allowance for bad and doubtful loans and advances 0 0
Loans and advances 2,33,28,446 1,31,11,300.87
Nature of other loans and advances OTHERS OTHERS
Details of loans and advances due by directors, other officers or others
[Abstract]
Loans and advances due by directors 0 0
Loans and advances due by other officers 0 0
Loans and advances due by others 0 0
Total loans and advances due by directors, other officers or others 0 0
Details of loans and advances due by firms or companies in which any
director is partner or director [Abstract]
Loans and advances due by firms in which any director is partner 0 0
Loans and advances due by private companies in which any director is
0 0
director
Loans and advances due by private companies in which any director is member 0 0
Total loans and advances due by firms or companies in which any director
0 0
is partner or director

67
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Subclassification of trade receivables [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Classification of assets based on security
Classification of assets based on security [Axis] Unsecured considered good [Member]
[Member]
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Subclassification and notes on liabilities and assets
[Abstract]
Trade receivables notes [Abstract]
Trade receivables [Abstract]
Subclassification of trade receivables
[Abstract]
Subclassification of trade receivables
[LineItems]
Breakup of trade receivables [Abstract]
Trade receivables, gross 5,85,924 14,13,180 5,85,924 14,13,180
Allowance for bad and doubtful debts 0 0 0 0
Total trade receivables 5,85,924 14,13,180 5,85,924 14,13,180
Details of trade receivables due by
directors, other officers or others
[Abstract]
Trade receivables due by directors 0 0
Trade receivables due by other officers 0 0
Trade receivables due by others 0 0
Total trade receivables due by
directors, other officers or 0 0
others
Details of trade receivables due by
firms or companies in which any director
is partner or director [Abstract]
Trade receivables due by firms in
0 0
which any director is partner
Trade receivables due by private
companies in which any director 0 0
is director
Trade receivables due by private
companies in which any director 0 0
is member
Total trade receivables due by firms
or companies in which any director is 0 0
partner or director

Classification of inventories [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Classification of inventories [Axis] Company total inventories [Member] Stock-in-trade [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Subclassification and notes on liabilities and assets
[Abstract]
Inventories notes [Abstract]
Inventories [Abstract]
Classification of inventories [Abstract]
Details of inventories [LineItems]
Inventories 23,31,697 28,13,237 17,32,993 19,78,100
Goods in transit 0 0 0 0
lower of cost and lower of cost and lower of cost and lower of cost and
Mode of valuation market value market value market value market value

68
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Classification of inventories [Table] ..(2)


Unless otherwise specified, all monetary values are in INR
Classification of inventories [Axis] Other inventories [Member] Other inventories, others [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Subclassification and notes on liabilities and assets
[Abstract]
Inventories notes [Abstract]
Inventories [Abstract]
Classification of inventories [Abstract]
Details of inventories [LineItems]
Inventories 5,98,704 8,35,137 5,98,704 8,35,137
Goods in transit 0 0 0 0
lower of cost and lower of cost and lower of cost and lower of cost and
Mode of valuation market value market value market value market value
Nature of other inventories CONSUMABLES CONSUMABLES CONSUMABLES CONSUMABLES

69
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Unless otherwise specified, all monetary values are in INR


01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of subclassification and notes on liabilities and assets
explanatory [TextBlock]
Trade payables, long-term 0 0
Gross amount due to customers for contract work, non-current 0 0
Others long-term, others 0 0
Total others, long-term 0 0
Total other long-term liabilities 0 0
Nature of other provisions others others
Current maturities of long-term debt 0 0
Current maturities of finance lease obligations 0 0
Interest accrued but not due on borrowings 0 0
Interest accrued and due on borrowings 0 0
Interest accrued but not due on public deposits 0 0
Interest accrued and due on public deposits 0 0
Debentures claimed but not paid 0 0
Income received in advance 0 0
Unpaid dividends 0 0
Application money received for allotment of securities and
0 0
due for refund, principal
Unpaid matured deposits and interest accrued thereon 0 0
Unpaid matured debentures and interest accrued thereon 0 0
Public deposit payable, current 0 0
Total other payables, current 0 0
Current liabilities portion of share application money pending
0 0
allotment
Total other current liabilities 0 0
Other non-current assets, others 7,50,000 7,50,000
Total other non-current assets 7,50,000 7,50,000
Nature of other non-current assets, others Preliminary expenses Preliminary expenses
Aggregate amount of trade receivables outstanding for period
4,18,489 3,22,114
exceeding six months
Share trade receivables joint ventures 0 0
Fixed deposits with banks 0 0
Other deposits with banks 0 0
Deposit repayment reserve account with banks 0 0
Other balances with banks 19,62,118.05 1,18,17,627.06
Total balance with banks 19,62,118.05 1,18,17,627.06
Cheques, drafts on hand 0 0
Cash on hand 3,04,311 2,09,278
Others 0 0
Total cash and cash equivalents 22,66,429.05 1,20,26,905.06
Other bank balances 0 0
Total cash and bank balances 22,66,429.05 1,20,26,905.06
Earmarked balances with banks 0 0
Balances held with banks to extent held as margin money 0 0
Balances held with banks to extent held as security against
0 0
borrowings
Balances held with banks to extent held as guarantees 0 0
Balances held with banks to extent held against other
0 0
commitments
Total balances held with banks to extent held as
margin money or security against borrowings, 0 0
guarantees or other commitments
Bank deposits with more than twelve months maturity 0 0
Unbilled revenue 0 0
Unamortised premium of forward contracts 0 0
Other unamortised expenses 10,48,597.97 3,73,788
Gross amount due from customers for contract work, current 0 0
Dividend receivable, subsidiaries 0 0
Dividend receivable, others 0 0
Total dividend receivable 0 0
Interest receivable 0 0

70
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Derivative assets 0 0
Tangible assets held for sale 0 0
Other current assets, others 76,35,171 79,06,684
Total other current assets 86,83,768.97 82,80,472
TDS, advance TDS, advance
Nature of other current assets tax, security deposit tax, security deposit
Share other current assets joint ventures 0 0

71
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[200700] Notes - Additional disclosures on balance sheet


Unless otherwise specified, all monetary values are in INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of additional balance sheet notes explanatory [TextBlock]
Claims against company not acknowledged as debt 0 0
Guarantees 88,51,190 88,51,190
Other money for which company is contingently liable 2,38,60,151 0
Total contingent liabilities 3,27,11,341 88,51,190
Estimated amount of contracts remaining to be executed on
0 0
capital account and not provided for
Uncalled liability on shares and other investments partly paid 0 0
Other commitments 0 0
Total commitments 0 0
Total contingent liabilities and commitments 3,27,11,341 88,51,190
Amount of dividends proposed to be distributed to equity shareholders 0 0
Amount of per share dividend proposed to be distributed to equity
[INR/shares] 0 [INR/shares] 0
shareholders
Amount of dividends proposed to be distributed to preference
0 0
shareholders
Amount of per share dividend proposed to be distributed to
[INR/shares] 0 [INR/shares] 0
preference shareholders
Arrears of fixed cumulative dividends on preference shares 0 0
Percentage of proposed dividend 0.00% 0.00%
Percentage of share capital held by foreign company 0.00% 0.00%
Value of share capital held by foreign company 0 0
Percentage of paid-up capital held by foreign holding company and
0.00% 0.00%
or with its subsidiaries
Value of paid-up capital held by foreign holding company and or
0 0
with its subsidiaries
Deposits accepted or renewed during period 0 0
Deposits matured and claimed but not paid during period 0 0
Deposits matured and claimed but not paid 0 0
Deposits matured but not claimed 0 0
Interest on deposits accrued and due but not paid 0 0
Additions to equity share warrants during period 0 0
Deductions in equity share warrants during period 0 0
Total changes in equity share warrants during period 0 0
Equity share warrants at end of period 0 0
Equity share warrants for existing members 0 0
Equity share warrants for others 0 0
Total equity share warrants 0 0
Share application money received during year 0 0
Share application money paid during year 0 0
Amount of share application money received back during year 0 0
Amount of share application money repaid returned back during year 0 0
Number of person share application money paid during year 0 0
Number of person share application money received during year 0 0
Number of person share application money paid as at end of year 0 0
Number of person share application money received as at end of year 0 0
Disclosure of whether all assets and liabilities are registered with
Yes Yes
company
Whether maintenance of cost records by company has been
mandated under Companies (Cost Records and Audit) Rules, No No
2014
Whether audit of cost records of company has been mandated
No No
under Rules specified in SN 1
Unclaimed share application refund money 0 0
Unclaimed matured debentures 0 0
Unclaimed matured deposits 0 0
Interest unclaimed amount 0 0

72
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Investment in subsidiary companies 0 0


Investment in government companies 0 0
Amount due for transfer to investor education and protection fund
0 0
(IEPF)
Number of warrants converted into equity shares during period 0 0
Number of warrants converted into preference shares during period 0 0
Number of warrants converted into debentures during period 0 0
Number of warrants issued during period (in foreign currency) 0 0
Number of warrants issued during period (INR) 0 0
Number of shareholders to whom shares are allotted under private
0 0
placement during period

[200800] Notes - Disclosure of accounting policies, changes in accounting policies and estimates
Unless otherwise specified, all monetary values are in INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of accounting policies, change in accounting policies and Textual information (27) Textual information (28)
changes in estimates explanatory [TextBlock] [See below] [See below]
Textual information (29) Textual information (30)
Disclosure of general information about company [TextBlock] [See below] [See below]
Textual information (31) Textual information (32)
Disclosure of accounting policies explanatory [TextBlock] [See below] [See below]

73
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (27)

Disclosure of accounting policies, change in accounting policies and changes in estimates explanatory [Text Block]
Notes to Financial Statements for the Year ended 31stMarch, 2019 .

1. A. COMPANY INFORMATION.

INSTITUTE OF GASTRO & KIDNEY CARE PRIVATE LIMITED is a private limited company domiciled in India. The company is engaged
in providing medical & healthcare services.

B. SIGNIFICANT ACCOUNTING POLICIES.

a) Basis of Preparation of Financial Statements

The financial statements have been prepared to comply with the Generally Accepted Accounting Principles in India (Indian GAAP) including the
Accounting Standards notified under the relevant provisions of the Companies Act, 2013.

These statements have been prepared on accrual basis under the historical cost convention.

b) Valuation of Inventories

Stock of inventories (medicine) has been valued at cost.

c) Fixed Assets

Fixed Assets are stated at cost of acquisition and subsequent improvement thereto. The cost of acquisition includes taxes, duties, freight and other
expenses related to acquisition and installation.

d) Depreciation

Depreciation on fixed assets has been provided as per Schedule II of the Companies Act, 2013 on the basis of WDV method.

e) Events occurring after Balance Sheet Date

Material events occurring after the Balance Sheet date are taken in cognizance.

f) Treatment of Contingencies

Contingencies which can be reasonably ascertained are provided for

g) Employee Benefits

i) Provident Fund & ESI has been accounted for.

ii) Gratuity is accounted for on cash basis.

74
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

h) Previous Year

Previous year figures are regrouped and rearranged wherever necessary to conform to current year's presentation in the financial statements.

75
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (28)

Disclosure of accounting policies, change in accounting policies and changes in estimates explanatory [Text Block]
Notes to Financial Statements for the Year ended 31stMarch, 2018 .

1. A. COMPANY INFORMATION.

INSTITUTE OF GASTRO & KIDNEY CARE PRIVATE LIMITED is a private limited company domiciled in India. The company is engaged
in providing medical & healthcare services.

B. SIGNIFICANT ACCOUNTING POLICIES.

a) Basis of Preparation of Financial Statements

The financial statements have been prepared to comply with the Generally Accepted Accounting Principles in India (Indian GAAP) including the
Accounting Standards notified under the relevant provisions of the Companies Act, 2013.

These statements have been prepared on accrual basis under the historical cost convention.

b) Valuation of Inventories

Stock of inventories (medicine) has been valued at cost.

c) Fixed Assets

Fixed Assets are stated at cost of acquisition and subsequent improvement thereto. The cost of acquisition includes taxes, duties, freight and other
expenses related to acquisition and installation.

d) Depreciation

Depreciation on fixed assets has been provided as per Schedule II of the Companies Act, 2013 on the basis of WDV method.

e) Events occurring after Balance Sheet Date

Material events occurring after the Balance Sheet date are taken in cognizance.

f) Treatment of Contingencies

Contingencies which can be reasonably ascertained are provided for

g) Employee Benefits

i) Provident Fund & ESI has been accounted for.

ii) Gratuity is accounted for on cash basis.

76
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

h) Previous Year

Previous year figures are regrouped and rearranged wherever necessary to conform to current year's presentation in the financial statements.

Textual information (29)

Disclosure of general information about company [Text Block]


INSTITUTE OF GASTRO & KIDNEY CARE PRIVATE LIMITED is a private limited company domiciled in India. The company is engaged
in providing medical & healthcare services

Textual information (30)

Disclosure of general information about company [Text Block]


INSTITUTE OF GASTRO & KIDNEY CARE PRIVATE LIMITED is a private limited company domiciled in India. The company is engaged
in providing medical & healthcare services

77
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (31)

Disclosure of accounting policies explanatory [Text Block]


B. SIGNIFICANT ACCOUNTING POLICIES.

a) Basis of Preparation of Financial Statements

The financial statements have been prepared to comply with the Generally Accepted Accounting Principles in India (Indian GAAP) including the
Accounting Standards notified under the relevant provisions of the Companies Act, 2013.

These statements have been prepared on accrual basis under the historical cost convention.

b) Valuation of Inventories

Stock of inventories (medicine) has been valued at cost.

c) Fixed Assets

Fixed Assets are stated at cost of acquisition and subsequent improvement thereto. The cost of acquisition includes taxes, duties, freight and other
expenses related to acquisition and installation.

d) Depreciation

Depreciation on fixed assets has been provided as per Schedule II of the Companies Act, 2013 on the basis of WDV method.

e) Events occurring after Balance Sheet Date

Material events occurring after the Balance Sheet date are taken in cognizance.

f) Treatment of Contingencies

Contingencies which can be reasonably ascertained are provided for

g) Employee Benefits

i) Provident Fund & ESI has been accounted for.

ii) Gratuity is accounted for on cash basis.

h) Previous Year

Previous year figures are regrouped and rearranged wherever necessary to conform to current year's presentation in the financial statements.

78
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Textual information (32)

Disclosure of accounting policies explanatory [Text Block]


B. SIGNIFICANT ACCOUNTING POLICIES.

a) Basis of Preparation of Financial Statements

The financial statements have been prepared to comply with the Generally Accepted Accounting Principles in India (Indian GAAP) including the
Accounting Standards notified under the relevant provisions of the Companies Act, 2013.

These statements have been prepared on accrual basis under the historical cost convention.

b) Valuation of Inventories

Stock of inventories (medicine) has been valued at cost.

c) Fixed Assets

Fixed Assets are stated at cost of acquisition and subsequent improvement thereto. The cost of acquisition includes taxes, duties, freight and other
expenses related to acquisition and installation.

d) Depreciation

Depreciation on fixed assets has been provided as per Schedule II of the Companies Act, 2013 on the basis of WDV method.

e) Events occurring after Balance Sheet Date

Material events occurring after the Balance Sheet date are taken in cognizance.

f) Treatment of Contingencies

Contingencies which can be reasonably ascertained are provided for

g) Employee Benefits

i) Provident Fund & ESI has been accounted for.

ii) Gratuity is accounted for on cash basis.

h) Previous Year

Previous year figures are regrouped and rearranged wherever necessary to conform to current year's presentation in the financial statements.

79
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[201700] Notes - Government grants


Unless otherwise specified, all monetary values are in INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of notes on government grants explanatory [TextBlock]
Capital subsidies or grants received from government authorities 0 0
Revenue subsidies or grants received from government authorities 0 0

[201200] Notes - Employee benefits


Unless otherwise specified, all monetary values are in INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Textual information (33) Textual information (34)
Disclosure of employee benefits explanatory [TextBlock] [See below] [See below]

Textual information (33)

Disclosure of employee benefits explanatory [Text Block]


a) Employee Benefits

i) Provident Fund & ESI has been accounted for.

ii) Gratuity is accounted for on cash basis

Textual information (34)

Disclosure of employee benefits explanatory [Text Block]


a) Employee Benefits

i) Provident Fund & ESI has been accounted for.

ii) Gratuity is accounted for on cash basis

80
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[201600] Notes - Related party

Disclosure of relationship and transactions between related parties [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Categories of related parties [Axis] KMP1 KMP2
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of relationship and transactions between
related parties [Abstract]
Disclosure of relationship and transactions between
related parties [LineItems]
KEDAR NATH KEDAR NATH SUBODH KUMAR SUBODH KUMAR
Name of related party PANDA PANDA DAS DAS
Country of incorporation or residence of related
INDIA INDIA INDIA INDIA
party
Permanent account number of related party ALUPP7287R ALUPP7287R AHSPD2066J AHSPD2066J
Key Management Key Management Key Management Key Management
Description of nature of related party relationship Personnel Personnel Personnel Personnel
REMUNERATION REMUNERATION & REMUNERATION REMUNERATION &
Description of nature of transactions with related
& PROFESSIONAL PROFESSIONAL & PROFESSIONAL PROFESSIONAL
party FEES FEES FEES FEES
Related party transactions [Abstract]
Services received related party transactions 1,32,52,244 1,24,38,755 27,50,327 28,21,159
Services received related party transactions,
37.00% 36.00% 8.00% 8.00%
percentage
Transaction relating to key management personnel
[Abstract]
Remuneration for key managerial personnel 48,00,000 48,00,000 7,00,000 12,00,000
Remuneration for key managerial personnel,
56.00% 48.00% 8.00% 12.00%
percentage
Amount written off during period in respect
0 0 0 0
of debts due from related parties
Amount written back during period in respect
0 0 0 0
of debts due to related parties

81
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of relationship and transactions between related parties [Table] ..(2)


Unless otherwise specified, all monetary values are in INR
Categories of related parties [Axis] KMP3 KMP4
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of relationship and transactions between
related parties [Abstract]
Disclosure of relationship and transactions between
related parties [LineItems]
PRAKASH PRAKASH BRUNDABAN BRUNDABAN
Name of related party CHANDRA DALAI CHANDRA DALAI NAHAK NAHAK
Country of incorporation or residence of related
INDIA INDIA INDIA INDIA
party
Permanent account number of related party AIIPD0686R AIIPD0686R ACBPN4528K ACBPN4528K
Key Management Key Management Key Management Key Management
Description of nature of related party relationship Personnel Personnel Personnel Personnel
REMUNERATION REMUNERATION & REMUNERATION REMUNERATION &
Description of nature of transactions with related
& PROFESSIONAL PROFESSIONAL & PROFESSIONAL PROFESSIONAL
party FEES FEES FEES FEES
Related party transactions [Abstract]
Services received related party transactions 1,30,23,944 1,24,38,755 28,27,640 27,70,100
Services received related party transactions,
37.00% 36.00% 8.00% 8.00%
percentage
Transaction relating to key management personnel
[Abstract]
Remuneration for key managerial personnel 12,00,000 12,00,000 7,00,000 12,00,000
Remuneration for key managerial personnel,
14.00% 12.00% 8.00% 12.00%
percentage
Amount written off during period in respect
0 0 0 0
of debts due from related parties
Amount written back during period in respect
0 0 0 0
of debts due to related parties

Disclosure of relationship and transactions between related parties [Table] ..(3)


Unless otherwise specified, all monetary values are in INR
Categories of related parties [Axis] KMP5 KMP6
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Disclosure of relationship and transactions between
related parties [Abstract]
Disclosure of relationship and transactions between
related parties [LineItems]
MANORANJAN MANORANJAN SUJATA
Name of related party MOHAPATRA MOHAPATRA TRIPATHY
SUJATA TRIPATHY

Country of incorporation or residence of related


INDIA INDIA INDIA INDIA
party
Permanent account number of related party ADRPM3649R ADRPM3649R AXFPT5729F AXFPT5729F
Key Management Key Management Key Management Key Management
Description of nature of related party relationship Personnel Personnel Personnel Personnel
REMUNERATION REMUNERATION &
Description of nature of transactions with related
& PROFESSIONAL PROFESSIONAL REMUNERATION REMUNERATION
party FEES FEES
Related party transactions [Abstract]
Services received related party transactions 33,00,670 36,00,000 0 0
Services received related party transactions,
9.00% 10.00% 0.00% 0.00%
percentage
Transaction relating to key management personnel
[Abstract]
Remuneration for key managerial personnel 6,00,000 6,00,000 6,00,000 6,00,000
Remuneration for key managerial personnel,
7.00% 6.00% 7.00% 6.00%
percentage
Amount written off during period in respect
0 0 0 0
of debts due from related parties
Amount written back during period in respect
0 0 0 0
of debts due to related parties

82
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Unless otherwise specified, all monetary values are in INR


01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of notes on related party explanatory [TextBlock]
Whether there are any related party transactions during year Yes Yes
Whether company is subsidiary company No No

[201400] Notes - Leases


Unless otherwise specified, all monetary values are in INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of leases explanatory [TextBlock]
Whether any operating lease has been converted to financial lease or
No No
vice-versa

[300300] Notes - Earnings per share


Unless otherwise specified, all monetary values are in INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of earnings per share explanatory [TextBlock]
Weighted average shares and adjusted weighted average shares [Abstract]
Basic weighted average shares [shares] 1,63,88,927 [shares] 1,54,91,493
Adjusted weighted average shares [shares] 1,63,88,927 [shares] 1,54,91,493
Diluted weighted average shares [shares] 1,63,88,927 [shares] 1,54,91,493
Adjustments of numerator to calculate basic earnings per share [Abstract]
Numerator to calculate basic earnings per share 1,94,39,106.23 1,41,25,584.81
Adjustments to reconcile numerator to calculate basic
earning per share to net profit or loss as per statement of 0 0
profit or loss
Profit (loss) for period 1,94,39,106.23 1,41,25,584.81
Adjustments of numerator to calculate diluted earnings per share [Abstract]
Numerator to calculate diluted earnings per share 1,94,39,106.23 1,41,25,584.81
Adjustments to reconcile numerator to calculate diluted
earning per share to net profit or loss as per statement of 0 0
profit or loss
Profit (loss) for period 1,94,39,106.23 1,41,25,584.81

[202800] Notes - Subsidiary information


Unless otherwise specified, all monetary values are in INR
01/04/2018
to
31/03/2019
Disclosure of subsidiary information explanatory [TextBlock]
Whether company has subsidiary companies No
Whether company has subsidiary companies which are yet to commence
No
operations
Whether company has subsidiary companies liquidated or sold during year No

83
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[201900] Notes - Income taxes


Unless otherwise specified, all monetary values are in INR
31/03/2019 31/03/2018
Disclosure of notes on income taxes explanatory [TextBlock]
Disclosure of breakup of deferred tax assets and deferred tax liabilities
[Abstract]
Components of deferred tax assets [Abstract]
Deferred tax asset, employee benefits 0 0
Deferred tax asset, expenditure disallowances 0 0
Deferred tax asset, depreciation 17,71,238 17,43,306
Deferred tax asset, provision doubtful debts 0 0
Deferred tax asset, sundry debtors 0 0
Deferred tax asset, unabsorbed depreciation 0 0
Deferred tax asset, unrealised carried forward losses 0 0
Deferred tax asset, VRS payment 0 0
Deferred tax in respect of business combinations 0 0
Deferred tax asset, other 0 0
Total deferred tax assets 17,71,238 17,43,306
Components of deferred tax liabilities [Abstract]
Deferred tax liability, depreciation 0 0
Deferred tax liability, export incentives 0 0
Deferred tax liability, investments 0 0
Deferred tax liability, provision doubtful debts 0 0
Deferred tax liability, provision employee benefits 0 0
Deferred tax liability, provision expenses 0 0
Deferred tax liability, technical know-how fees 0 0
Deferred tax liability, other 0 0
Total deferred tax liabilities 0 0

[202400] Notes - Investments in associates


Unless otherwise specified, all monetary values are in INR
01/04/2018
to
31/03/2019
Disclosure of notes on investment in associates explanatory [TextBlock]
Whether company has invested in associates No
Whether company has associates which are yet to commence operations No
Whether company has associates liquidated or sold during year No

[202500] Notes - Financial reporting of interests in joint ventures


Unless otherwise specified, all monetary values are in INR
01/04/2018
to
31/03/2019
Disclosure of notes on interests in joint ventures explanatory [TextBlock]
Whether company has invested in joint ventures No
Whether company has joint ventures which are yet to commence operations No
Whether company has joint ventures liquidated or sold during year No

84
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[202700] Notes - Cash flow statements


Unless otherwise specified, all monetary values are in INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Disclosure of cash flow statement explanatory [TextBlock]
Cash and cash equivalents if different from balance sheet [Abstract]
Cash and cash equivalents cash flow statement 22,66,429.05 1,20,26,905.06
Total cash and cash equivalents 22,66,429.05 1,20,26,905.06
Income taxes paid (refund) [Abstract]
Income taxes paid (refund), classified as operating activities 56,32,799 56,20,264
Income taxes paid (refund), classified as investing activities 0 0
Income taxes paid (refund), classified as financing activities 0 0
Total income taxes paid (refund) 56,32,799 56,20,264

85
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[100200] Statement of profit and loss


Unless otherwise specified, all monetary values are in INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Statement of profit and loss [Abstract]
Disclosure of revenue from operations [Abstract]
Disclosure of revenue from operations for other than finance company
[Abstract]
Revenue from sale of products 6,37,94,771.17 6,14,79,151.01
Revenue from sale of services 11,95,18,857.9 11,06,70,969
Other operating revenues 0 0
Excise duty 0 0
Service tax collected 0 0
Other duties taxes collected 0 0
Total revenue from operations other than finance company 18,33,13,629.07 17,21,50,120.01
Disclosure of revenue from operations for finance company [Abstract]
Revenue from interest 0 0
Revenue from other financial services 0 0
Total revenue from operations finance company 0 0
Total revenue from operations 18,33,13,629.07 17,21,50,120.01
Other income 26,83,667.08 48,40,937.97
Total revenue 18,59,97,296.15 17,69,91,057.98
Expenses [Abstract]
Cost of materials consumed 0 0
Changes in inventories of finished goods, work-in-progress and
4,81,540 -11,73,365.43
stock-in-trade
Employee benefit expense 3,89,15,022.43 3,92,63,150.06
Finance costs 0 0
Depreciation, depletion and amortisation expense [Abstract]
Depreciation expense 66,75,290 1,01,85,962
Amortisation expense 90,486 1,64,724
Depletion expense 0 0
Total depreciation, depletion and amortisation expense 67,65,776 1,03,50,686
Expenditure on production, transportation and other expenditure
0 0
pertaining to exploration and production activities
CSR expenditure 0 0
Other expenses 11,28,43,838.49 10,89,83,553.54
Total expenses 15,90,06,176.92 15,74,24,024.17
Total profit before prior period items, exceptional items, extraordinary
2,69,91,119.23 1,95,67,033.81
items and tax
Total profit before extraordinary items and tax 2,69,91,119.23 1,95,67,033.81
Total profit before tax 2,69,91,119.23 1,95,67,033.81
Tax expense [Abstract]
Current tax 75,79,945 56,32,799
Deferred tax -27,932 -1,91,350
Total tax expense 75,52,013 54,41,449
Total profit (loss) for period from continuing operations 1,94,39,106.23 1,41,25,584.81
Profit (loss) from discontinuing operations before tax 0 0
Tax expense of discontinuing operations 0 0
Total profit (loss) from discontinuing operation after tax 0 0
Total profit (loss) for period before minority interest 1,94,39,106.23 1,41,25,584.81
Profit (loss) of minority interest 0 0
Share of profit (loss) of associates 0 0
Total profit (loss) for period 1,94,39,106.23 1,41,25,584.81
Earnings per equity share [Abstract]
Basic earning per equity share [INR/shares] 1.19 [INR/shares] 0.91
Diluted earnings per equity share [INR/shares] 1.19 [INR/shares] 0.91
Basic earning per equity share before extraordinary items [INR/shares] 1.19 [INR/shares] 0.91
Diluted earnings per equity share before extraordinary items [INR/shares] 1.19 [INR/shares] 0.91
Nominal value of per equity share [INR/shares] 10 [INR/shares] 10

86
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[300500] Notes - Subclassification and notes on income and expenses


Unless otherwise specified, all monetary values are in INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Subclassification and notes on income and expense explanatory [TextBlock]
Disclosure of revenue from sale of products [Abstract]
Revenue from sale of products [Abstract]
Revenue from sale of products, gross 6,37,94,771.17 6,14,79,151.01
Brokerage discounts rebates on revenue from sale of products 0 0
Returns on revenue from sale of products 0 0
Other allowances deductions on revenue from sale of products 0 0
Total revenue from sale of products 6,37,94,771.17 6,14,79,151.01
Disclosure of revenue from sale of services [Abstract]
Revenue from sale of services [Abstract]
Revenue from sale of services, gross 11,95,18,857.9 11,06,70,969
Brokerage discounts rebates on revenue from sale of services 0 0
Returns on revenue from sale of services 0 0
Other allowances deductions on revenue from sale of services 0 0
Total revenue from sale of services 11,95,18,857.9 11,06,70,969
Disclosure of other operating revenues [Abstract]
Other operating revenues [Abstract]
Net gain/loss on foreign currency fluctuations treated as other
0 0
operating revenue
Miscellaneous other operating revenues 0 0
Total other operating revenues 0 0
Disclosure of other income [Abstract]
Interest income [Abstract]
Interest income on current investments [Abstract]
Interest on fixed deposits, current investments 18,82,568 10,14,848
Interest from customers on amounts overdue, current investments 0 0
Interest on current intercorporate deposits 0 0
Interest on current debt securities 0 0
Interest on current government securities 0 0
Interest on other current investments 0 0
Total interest income on current investments 18,82,568 10,14,848
Interest income on long-term investments [Abstract]
Interest on fixed deposits, long-term investments 0 0
Interest from customers on amounts overdue, long-term investments 0 0
Interest on long-term intercorporate deposits 0 0
Interest on long-term debt securities 0 0
Interest on long-term government securities 0 0
Interest on other long-term investments 0 0
Total interest income on long-term investments 0 0
Total interest income 18,82,568 10,14,848
Dividend income [Abstract]
Dividend income current investments [Abstract]
Dividend income current investments from subsidiaries 0 0
Dividend income current equity securities 0 0
Dividend income current mutual funds 0 0
Dividend income current investments from others 0 0
Total dividend income current investments 0 0
Dividend income long-term investments [Abstract]
Dividend income long-term investments from subsidiaries 0 0
Dividend income long-term equity securities 0 0
Dividend income long-term mutual funds 0 0
Dividend income long-term investments from others 0 0
Total dividend income long-term investments 0 0
Total dividend income 0 0
Net gain/loss on sale of investments [Abstract]
Net gain/loss on sale of current investments 0 0

87
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Net gain/loss on sale of long-term investments 0 0


Total net gain/loss on sale of investments 0 0
Rental income on investment property [Abstract]
Rental income on investment property, current 0 0
Rental income on investment property, long-term 0 0
Total rental income on investment property 0 0
Other non-operating income [Abstract]
Net gain/loss on foreign currency fluctuations treated as other
0 0
income
Surplus on disposal, discard, demolishment and destruction of
0 0
depreciable tangible asset
Gain on disposal of intangible asset 0 0
Amount credited to profit and loss as transfer from
revaluation reserve on account of additional 0 0
depreciation charged on revalued tangible assets
Excess provision diminution in value investment written back 0 0
Excess provisions bad doubtful debts advances written back 0 0
Income government grants subsidies 0 0
Income export incentives 0 0
Income import entitlements 0 0
Income insurance claims 0 0
Income from subsidiaries 0 0
Interest on income tax refund 0 0
Income on brokerage commission 0 0
Income on sales tax benefit 0 0
Excess provisions written back 0 0
Liabilities written off 0 0
Other allowances deduction other income 0 0
Miscellaneous other non-operating income 8,01,099.08 38,26,089.97
Total other non-operating income 8,01,099.08 38,26,089.97
Income from pipeline transportation 0 0
Total other income 26,83,667.08 48,40,937.97
Disclosure of finance cost [Abstract]
Interest expense [Abstract]
Interest expense long-term loans [Abstract]
Interest expense long-term loans, banks 0 0
Interest expense long-term loans, others 0 0
Total interest expense long-term loans 0 0
Interest expense short-term loans [Abstract]
Interest expense short-term loans, banks 0 0
Interest expense short-term loans, others 0 0
Total interest expense short-term loans 0 0
Interest expense deposits 0 0
Interest expense debt securities 0 0
Interest expense other borrowings 0 0
Interest expense borrowings 0 0
Interest lease financing 0 0
Other interest charges 0 0
Total interest expense 0 0
Other borrowing costs 0 0
Net gain/loss on foreign currency transactions and translations
0 0
treated as finance costs
Total finance costs 0 0
Share finance costs joint ventures 0 0
Employee benefit expense [Abstract]
Salaries and wages 2,69,69,584 2,60,69,083
Managerial remuneration [Abstract]
Remuneration to directors [Abstract]
Salary to directors 86,00,000 1,00,40,000
Commission to directors 0 0
Other benefits to directors 0 0
Total remuneration to directors 86,00,000 1,00,40,000
Remuneration to manager [Abstract]
Salary to manager 0 0
Commission to manager 0 0

88
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Other benefits to manager 0 0


Total remuneration to manager 0 0
Total managerial remuneration 86,00,000 1,00,40,000
Contribution to provident and other funds [Abstract]
Contribution to provident and other funds for contract labour 0 0
Contribution to provident and other funds for others 9,39,212 10,57,564
Total contribution to provident and other funds 9,39,212 10,57,564
Expense on employee stock option scheme and employee stock purchase plan 0 0
Commission employees 0 0
Employee medical insurance expenses 7,65,124 6,14,659
Leave encashment expenses 0 0
Gratuity 0 0
Pension schemes 0 0
Voluntary retirement compensation 0 0
Other retirement benefits 0 0
Staff welfare expense 16,41,102.43 14,81,844.06
Other employee related expenses 0 0
Total employee benefit expense 3,89,15,022.43 3,92,63,150.06
Share employee benefit expense joint ventures 0 0
Breakup of other expenses [Abstract]
Consumption of stores and spare parts 9,42,29,569.82 9,02,76,876.8
Power and fuel 0 0
Rent 48,07,274 46,82,031
Repairs to building 0 0
Repairs to machinery 23,74,505.43 39,64,973
Insurance 1,26,438 1,11,009
Rates and taxes excluding taxes on income [Abstract]
Central excise duty 0 0
Purchase tax 2,26,600 0
Other cess taxes 0 0
Cost taxes other levies by government local authorities 0 4,199.66
Provision wealth tax 0 0
Total rates and taxes excluding taxes on income 2,26,600 4,199.66
Research development expenditure 0 0
Subscriptions membership fees 0 0
Electricity expenses 20,19,007 20,70,553
Telephone postage 74,771 74,250
Printing stationery 7,16,184 6,98,679
Information technology expenses 0 0
Travelling conveyance 36,142 3,69,657
Catering canteen expenses 0 0
Entertainment expenses 0 0
Legal professional charges 66,291 1,488
Training recruitment expenses 42,906.7 1,04,269
Vehicle running expenses 0 0
Safety security expenses 15,01,668 13,98,797
Directors sitting fees 0 0
Commission to directors other than whole time director or managing
0 0
director or manager
Donations subscriptions 0 0
Books periodicals 17,010 14,072
Seminars conference expenses 4,11,342 0
Registration filing fees 97,200 79,504
Custodial fees 0 0
Bank charges 7,90,748.76 7,54,594
Guest house expenses 0 0
Advertising promotional expenses 94,368 24,712
After sales service expenses 0 0
Warranty claim expenses 0 0
Commission paid sole selling agents 0 0
Commission paid other selling agents 0 0
Commission paid sole buying agents 0 0
Transportation distribution expenses 9,756 7,930
Secondary packing expenses 0 0
Discounting charges 0 0

89
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Guarantee commission 0 0
Cost repairs maintenance other assets 0 0
Cost transportation [Abstract]
Cost freight 0 0
Cost octroi 0 0
Cost loading and unloading 0 0
Cost other transporting 0 0
Total cost transportation 0 0
Cost lease rentals 0 0
Cost effluent disposal 0 0
Provision for cost of restoration 0 0
Cost warehousing 0 0
Cost water charges 0 0
Cost technical services 0 0
Cost royalty 0 0
Provision bad doubtful debts created 0 0
Provision bad doubtful loans advances created 0 0
Adjustments to carrying amounts of investments [Abstract]
Provision diminution value current investments created 0 0
Provision diminution value long-term investments created 0 0
Total adjustments to carrying amounts of investments 0 0
Net provisions charged [Abstract]
Provision warranty claims created 0 0
Provision statutory liabilities created 0 0
Provision restructuring created 0 0
Other provisions created 0 0
Total net provisions charged 0 0
Discount issue shares debentures written off [Abstract]
Discount issue shares written off 0 0
Discount issue debentures written off 0 0
Total discount issue shares debentures written off 0 0
Write-off assets [Abstract]
Miscellaneous expenditure written off [Abstract]
Financing charges written off 0 0
Voluntary retirement compensation written off 0 0
Technical know-how written off 0 0
Other miscellaneous expenditure written off 0 0
Total miscellaneous expenditure written off 0 0
Fixed assets written off 0 0
Inventories written off 0 0
Investments written off 0 0
Bad debts written off 0 0
Bad debts advances written off 0 0
Other assets written off 0 0
Total write-off assets 0 0
Loss on disposal of intangible asset 0 0
Loss on disposal, discard, demolishment and destruction of depreciable
0 0
tangible asset
Contract cost [Abstract]
Site labour supervision cost contracts 0 0
Material cost contract 0 0
Depreciation assets contracts 0 0
Cost transportation assets contracts 0 0
Hire charges assets contracts 0 0
Cost design technical assistance contracts 0 0
Warranty cost contracts 0 0
Other claims contracts 0 0
Sale material scrap other assets contracts 0 0
Overhead costs apportioned contracts [Abstract]
Insurance cost apportioned contract 0 0
Design technical assistance apportioned contracts 0 0
Other overheads apportioned contracts 0 0
Total overhead costs apportioned contracts 0 0
Total contract cost 0 0
Cost dry wells 0 0

90
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Operating and maintenance cost of emission and other pollution


0 0
reduction equipments
Payments to auditor [Abstract]
Payment for audit services 1,45,000 1,25,000
Payment for taxation matters 0 0
Payment for company law matters 0 0
Payment for other services 0 0
Payment for reimbursement of expenses 0 0
Total payments to auditor 1,45,000 1,25,000
Payments to cost auditor [Abstract]
Payment for cost audit charges 0 0
Payment for cost compliance report 0 0
Payment for other cost services 0 0
Payment to cost auditor for reimbursement of expenses 0 0
Total payments to cost auditor 0 0
Miscellaneous expenses 50,57,056.78 42,20,959.08
Total other expenses 11,28,43,838.49 10,89,83,553.54
Breakup of expenditure on production, transportation and other
expenditure pertaining to exploration and production activities
[Abstract]
Royalty pertaining to exploration and production activities 0 0
Cess pertaining to exploration and production activities 0 0
Education cess pertaining to exploration and production activities 0 0
National calamity contingency duty pertaining to exploration and
0 0
production activities
Extraction cost pertaining to exploration and production activities 0 0
Sales tax pertaining to exploration and production activities 0 0
Geological and geophysical expenditure pertaining to exploration and
0 0
production activities
Administrative expenditure pertaining to exploration and production
0 0
activities
Research and development expenditure pertaining to exploration and
0 0
production activities
Pipeline operation and maintenance expenditure pertaining to
0 0
exploration and production activities
Other expenditure pertaining to exploration and production activities 0 0
Total expenditure on production, transportation and other
0 0
expenditure pertaining to exploration and production activities
Current tax [Abstract]
Current tax pertaining to previous years 0 0
Current tax pertaining to current year 75,79,945 56,32,799
MAT credit recognised during year 0 0
Total current tax 75,79,945 56,32,799

[300600] Notes - Additional information statement of profit and loss

Details of raw materials consumed [Table] ..(1)


Unless otherwise specified, all monetary values are in INR
Categories of raw materials consumed [Axis] Raw materials consumed [Member] Raw materials consumed 1 [Member]
01/04/2018 01/04/2017 01/04/2018 01/04/2017
to to to to
31/03/2019 31/03/2018 31/03/2019 31/03/2018
Additional information on profit and loss account
[Abstract]
Additional details in case of manufacturing companies
[Abstract]
Details of raw materials consumed [Abstract]
Details of raw materials consumed [LineItems]
Description of raw materials category NA NA NA NA
Total raw materials consumed 0 0 0 0

91
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Unless otherwise specified, all monetary values are in INR


01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018
Additional information on profit and loss account explanatory [TextBlock]
Changes in inventories of stock-in-trade 4,81,540 -11,73,365.43
Total changes in inventories of finished goods, work-in-progress and
4,81,540 -11,73,365.43
stock-in-trade
Revenue hospitals healthcare clinics 11,95,18,857.9 11,06,70,969
Total gross income from services rendered 11,95,18,857.9 11,06,70,969
Value of imports of raw materials 0 0
Value of imports of components and spare parts 0 0
Value of imports of capital goods 0 0
Total value of imports calculated on CIF basis 0 0
Expenditure on royalty 0 0
Expenditure on know-how 0 0
Expenditure on professional and consultation fees 0 0
Expenditure on interest 0 0
Expenditure on other matters 0 0
Expenditure on dividend paid 0 0
Total expenditure in foreign currency 0 0
Final dividend remitted in foreign currency 0 0
Interim dividend remitted in foreign currency 0 0
Special dividend remitted in foreign currency 0 0
Total amount of dividend remitted in foreign currency 0 0
FOB value of manufactured goods exported 0 0
FOB value of traded goods exported 0 0
Total earnings on export of goods calculated on FOB basis 0 0
Earnings on royalty 0 0
Earnings on know-how 0 0
Earnings on professional and consultation fees 0 0
Total earnings on royalty, know-how, professional and
0 0
consultation fees
Earnings on interest 0 0
Earnings on dividend 0 0
Total earnings on interest and dividend 0 0
Earnings on other income 0 0
Total earnings in foreign currency 0 0
Domestic sale manufactured goods 0 0
Domestic sale traded goods 6,37,94,771.17 6,14,79,151.01
Total domestic turnover goods, gross 6,37,94,771.17 6,14,79,151.01
Export sale manufactured goods 0 0
Export sale traded goods 0 0
Total export turnover goods, gross 0 0
Total revenue from sale of products 6,37,94,771.17 6,14,79,151.01
Domestic revenue services 11,95,18,857.9 11,06,70,969
Export revenue services 0 0
Total revenue from sale of services 11,95,18,857.9 11,06,70,969
Capital expenditure in foreign currency 0 0
Gross value of transaction with related parties as per AS-18 0 0
Bad debts of related parties as per AS-18 0 0

[300100] Notes - Revenue


Unless otherwise specified, all monetary values are in INR
01/04/2018 01/04/2017
to to
31/03/2019 31/03/2018

Disclosure of revenue explanatory [TextBlock] NA NA

Share revenue from operations joint ventures 0 0

92
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

[202200] Notes - Effects of changes in foreign exchange rates


Unless otherwise specified, all monetary values are in INR
31/03/2019 31/03/2018
Disclosure of notes on effect of changes in foreign exchange rates
explanatory [TextBlock]
Details of change in classification of significant foreign operation
[Abstract]
Impact of change in classification of significant foreign operation
0 0
on shareholders' fund

[300700] Notes - Key managerial personnels and directors remuneration and other information

Disclosure of key managerial personnels and directors and remuneration to key managerial personnels and directors [Table] ..(1)
Unless otherwise specified, all monetary values are in INR
Key managerial personnels and directors [Axis] DIRECTOR1 DIRECTOR2 DIRECTOR3 DIRECTOR4
01/04/2018 01/04/2018 01/04/2018 01/04/2018
to to to to
31/03/2019 31/03/2019 31/03/2019 31/03/2019
Disclosure of key managerial personnels and directors and
remuneration to key managerial personnels and directors
[Abstract]
Disclosure of key managerial personnels and directors
and remuneration to key managerial personnels and
directors [LineItems]
KEDAR NATH SUBODH KUMAR P R A K A S H BRUNDABAN
Name of key managerial personnel or director PANDA DAS CHANDRA DALAI NAHAK
Director identification number of key managerial
03519663 03529450 03529446 03519673
personnel or director
Date of birth of key managerial personnel or
08/08/1967 26/12/1971 20/07/1969 18/03/1968
director
Designation of key managerial personnel or director Director Director Director Director
Qualification of key managerial personnel or
DOCTOR DOCTOR DOCTOR DOCTOR
director
Shares held by key managerial personnel or director [shares] 37,39,154 [shares] 33,13,888 [shares] 28,34,093 [shares] 31,25,427
Key managerial personnel or director remuneration
[Abstract]
Gross salary to key managerial personnel or
director [Abstract]
Salary key managerial personnel or director 48,00,000 7,00,000 12,00,000 7,00,000
Gross salary to key managerial personnel or
48,00,000 7,00,000 12,00,000 7,00,000
director
Total key managerial personnel or director
48,00,000 7,00,000 12,00,000 7,00,000
remuneration

93
INSTITUTE OF GASTRO AND KIDNEY CARE PRIVATE LIMITED Standalone Financial Statements for period 01/04/2018 to 31/03/2019

Disclosure of key managerial personnels and directors and remuneration to key managerial personnels and directors [Table] ..(2)
Unless otherwise specified, all monetary values are in INR
Key managerial personnels and directors [Axis] DIRECTOR5 DIRECTOR6 KMP1 KMP2
01/04/2018 01/04/2018 01/04/2018 01/04/2018
to to to to
31/03/2019 31/03/2019 31/03/2019 31/03/2019
Disclosure of key managerial personnels and directors and
remuneration to key managerial personnels and directors
[Abstract]
Disclosure of key managerial personnels and directors
and remuneration to key managerial personnels and
directors [LineItems]
MANORANJAN SUJATA PADMA CHARAN
Name of key managerial personnel or director MOHAPATRA TRIPATHY PANDA
SUJATA BEHERA

Director identification number of key managerial


07493683 07493681
personnel or director
Permanent account number of key managerial
ABCPP2783L DMHPB2502N
personnel or director
Date of birth of key managerial personnel or
25/06/1968 09/03/1969 05/06/1964 03/05/1989
director
Designation of key managerial personnel or director Managing Director Director CFO Company Secretary
Qualification of key managerial personnel or
DOCTOR DOCTOR CA CS
director
Shares held by key managerial personnel or director [shares] 10,23,290 [shares] 0 [shares] 0 [shares] 0
Key managerial personnel or director remuneration
[Abstract]
Gross salary to key managerial personnel or
director [Abstract]
Salary key managerial personnel or director 6,00,000 6,00,000 5,92,500 15,000
Gross salary to key managerial personnel or
6,00,000 6,00,000 5,92,500 15,000
director
Total key managerial personnel or director
6,00,000 6,00,000 5,92,500 15,000
remuneration

[301000] Notes - Corporate social responsibility


Unless otherwise specified, all monetary values are in INR
01/04/2018
to
31/03/2019
Disclosure of corporate social responsibility explanatory [TextBlock]
Whether provisions of corporate social responsibility are applicable on
No
company

94

Вам также может понравиться